BRPI0514263B1 - Método para a síntese de bis-3,6-[4-aminobutil]-2,5- dicetopiperazina n-protegida - Google Patents
Método para a síntese de bis-3,6-[4-aminobutil]-2,5- dicetopiperazina n-protegida Download PDFInfo
- Publication number
- BRPI0514263B1 BRPI0514263B1 BRPI0514263-6A BRPI0514263A BRPI0514263B1 BR PI0514263 B1 BRPI0514263 B1 BR PI0514263B1 BR PI0514263 A BRPI0514263 A BR PI0514263A BR PI0514263 B1 BRPI0514263 B1 BR PI0514263B1
- Authority
- BR
- Brazil
- Prior art keywords
- fact
- synthesis
- lysine
- hours
- cbz
- Prior art date
Links
- 0 OC(C=CC(*CCCCC(C(*C1CCCCNC(C=CC(O)=O)=O)=O)NC1=O)=O)=O Chemical compound OC(C=CC(*CCCCC(C(*C1CCCCNC(C=CC(O)=O)=O)=O)NC1=O)=O)=O 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/14—Phosphorus; Compounds thereof
- B01J27/16—Phosphorus; Compounds thereof containing oxygen, i.e. acids, anhydrides and their derivates with N, S, B or halogens without carriers or on carriers based on C, Si, Al or Zr; also salts of Si, Al and Zr
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
catálise de síntese de dicetopiperazina. a presente invenção se refere a um método para a síntese de bis-3, 6- [4-aminobutil]-2, 5-dicetopiperazina n protegida incluindo a etapa de aquecimento de uma solução de lisina <sym>protegida na presença de um catalisador selecionado do grupo consistindo em ácido sulfúrico, ácido fosfórico, e pentóxido fosforoso.
Description
(54) Título: MÉTODO PARA A SÍNTESE DE BIS-3,6-[4-AMINOBUTIL]-2,5-DICETOPIPERAZINA NPROTEGIDA (51) Int.CI.: C07D 241/08 (30) Prioridade Unionista: 20/08/2004 US 60/603,340 (73) Titular(es): MANNKIND CORPORATION (72) Inventor(es): JOHN J. STEVENSON; DESTARDI MOYE-SHERMAN
1/14 “MÉTODO PARA A SÍNTESE DE BIS-3,6-[4-AMINOBUTIL]-2,5DICETOPIPERAZINA N-PROTEGIDA”
APLICAÇÕES RELATADAS [001]O presente pedido reivindica prioridade sob 35 U.S.C. § 119(e) para o pedido de patente provisório dos Estados Unidos número 60/603.340 depositado dia 20 de agosto de 2004.
CAMPO DA INVENÇÃO [002]Esta invenção está geralmente no campo de síntese química. Mais particularmente se refere à síntese melhorada de bis-3,6-[4-aminobutil]-2,5dicetopiperazinas N-protegidas.
ANTECEDENTES DA INVENÇÃO [003]A distribuição de fármacos tem sido um desafio persistente nas técnicas farmacêuticas, particularmente quando um fármaco é instável e/ou fracamente absorvido em lócus no corpo ao qual é administrado. Uma classe tal de fármacos inclui as 2,5-dicetopiperazinas tendo a estrutura geral de fórmula 1.
Fórmula 1 [004]Estas 2,5-dicetopiperazinas têm se mostrado úteis em distribuição de fármacos, particularmente, aqueles contendo grupos ácidos (ver por exemplo os documentos U.S. 5.352.461 intitulado Self-assembling diketopiperazine drug delivery system; 5.503.852 intitulado Method for making self-assembling diketopiperazine drug delivery system; 6.071.497 intitulado Microparticles for lung delivery comprising diketopiperazine; e 6.331.318 intitulado Carbon-substituted diketopiperazine delivery system, cada um dos quais está incorporado aqui por referência em sua
Petição 870180014326, de 22/02/2018, pág. 10/31
2/14 totalidade para tudo que ensina com relação às dicetopiperazinas e à distribuição de fármacos mediada por dicetopiperazinas). As dicetopiperazinas podem ser formadas em partículas que incorporam um fármaco ou partículas nas quais um medicamento pode ser absorvido. A combinação de um fármaco e uma dicetopiperazina pode fornecer uma estabilidade melhorada do medicamento. As partículas podem ser administradas por várias vias de administração. Como pós secos estas partículas podem ser distribuídas a áreas específicas do sistema respiratório, dependendo do tamanho da partícula. As partículas podem ser feitas pequenas o bastante para incorporação em formas de dosagem de suspensão intravenosa. A distribuição oral também é possível usando uma suspensão, ou como partículas prensadas em comprimidos ou contidas em uma cápsula. Estas dicetopiperazinas também podem facilitar a absorção do fármaco associado.
[005]Uma etapa convencional na síntese de 2,5- dicetopiperazinas inclui a preparação de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida pela condensação térmica de lisina. Processos de fabricação comerciais usuais utilizam (Nbenziloxicarbonil)-lisina (Cbz-L-lisina) para produzir bis-3,6-[(N-benziloxicarbonil)- 4aminobutil]-2,5-diceto-piperazina (DKP1). Este processo envolve o aquecimento de Cbz-L-lisina em m-cresol por 18-22 horas a 160°C-170°C, e fornece DKP1 em um rendimento médio de cerca de 47,5% após a recristalização de ácido acético glacial.
[006]Portanto, é um objetivo da presente invenção fornecer métodos melhorados de síntese para dicetopiperazinas.
SUMÁRIO DA INVENÇÃO [007]A presente invenção fornece métodos para a síntese de dicetopiperazinas usando catalisadores tais que tempos de reação mais rápidos e maiores rendimentos são alcançados comparados à(s) etapa(s)/método(s) convencionais. A utilização do catalisador da presente invenção, pentóxido de fósforo, em uma reação de ciclocondensação, fornece para a síntese de dicetopiperazinas de rendimento maior
Petição 870180014326, de 22/02/2018, pág. 11/31
3/14 e pureza maior em tempos de reação mais curtos sobre a(s) etapa(s)/método(s) convencionais.
[008]A presente invenção fornece um método para a síntese de bis-3,6-[4aminobutil]-2,5-dicetopiperazina N-protegida compreendendo a etapa de aquecimento de uma solução de lisina com ε-amino protegido na presença de um catalisador selecionado do grupo consistindo em ácido sulfúrico (H2SO4), ácido fosfórico (H3PO4) e pentóxido de fósforo (P2O5).
[009]Uma modalidade da presente invenção fornece um método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida em que a lisina com ε-amino protegido é (N-benziloxicarbonil)-lisina (Cbz-L-lisina) e o produto é a bis-3,6[(N-benziloxicarbonil)-4-aminobutil]-2,5-dicetopiperazina (DKP1).
[0010]Outra modalidade da presente invenção fornece um método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida em que a solução é aquecida a uma temperatura alvo de cerca de 160°C a 170°C Esta temperatura alvo preferivelmente é alcançada em cerca de 4 a 6 horas.
[0011]Ainda em uma outra modalidade da presente invenção um método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida compreendendo a etapa de aquecimento de uma solução de lisina com ε-amino protegido na presença de um catalisador é fornecida em que a síntese está substancialmente completa dentro de cerca de 10 horas de alcance de uma temperatura alvo. Mais preferivelmente, a síntese está substancialmente completa dentro de cerca de 8 horas, 6 horas, 4 horas, 3 horas, ou 2 horas de alcance de uma temperatura alvo. Ainda mais preferivelmente, a síntese está substancialmente completa dentro de cerca de 1,5 horas de alcance de uma temperatura alvo.
[0012]Outra modalidade da presente invenção fornece um método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida compreendendo a etapa de aquecimento de uma solução de lisina com ε-amino protegido, tal como (NPetição 870180014326, de 22/02/2018, pág. 12/31
4/14 benziloxicarbonil)-lisina (Cbz-L-lisina) na presença de um catalisador, tal como pentóxido de fósforo, em que a síntese tem um rendimento maior que cerca de 50%.
[0013]Outra modalidade da presente invenção fornece um método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina N-protegida na presença do catalisador pentóxido de fósforo, a concentração de pentóxido de fósforo é de cerca de 5% a 10%.
[0014]Estes e outros objetivos, vantagens e características da invenção serão mais amplamente compreendidos e apreciados por referência ao relatório descritivo escrito.
BREVE DESCRIÇÃO DOS DESENHOS [0015]FIG. 1 ilustra um fluxograma de síntese de 2,5-diceto-3,6-di(4fumarilaminobutil)piperazina (fumaril dicetopiperazina, FDKP) de acordo com um aspecto da presente invenção.
[0016]FIG. 2 ilustra um fluxograma de síntese de bis-3,6- [(N- benziloxicarbonil)-4- aminobutil]- 2,5-diketopiperazine (DKP1 ) de acordo com um aspecto da presente invenção.
[0017]FIG. 3 ilustra a conversão de (N-benziloxicarbonil)-lisina) Cbz-L-lisina a DKP1 usando os métodos de catálise de ácido sulfúrico de acordo com um aspecto da presente invenção.
[0018]FIG. 4 ilustra a conversão de Cbz-L-lisina a DKP1 usando os métodos de catálise de ácido fosfórico de acordo com um aspecto da presente invenção.
[0019]FIG. 5 ilustra a conversão de Cbz-L-lisina a DKP1 usando os métodos de catálise de pentóxido de fósforo de acordo com um aspecto da presente invenção.
[0020]FIG. 6 ilustra uma comparação dos três catalisadores de acordo com um aspecto da presente invenção.
[0021]FIG. 7 ilustra uma seqüência reacional da ciclodimerização catalisada
Petição 870180014326, de 22/02/2018, pág. 13/31
5/14 por P2O5 de acordo com um aspecto da presente invenção.
[0022]FIG. 8 ilustra o rendimento total de DKP1 versus tempo usando o catalisador de pentóxido de fósforo da presente invenção (escala da reação de 5 litros).
DESCRIÇÃO DETALHADA DA INVENÇÃO [0023]A presente invenção fornece métodos para a síntese de dicetopiperazinas usando catalisadores tais que tempos de reação mais rápidos e rendimentos mais altos são alcançados comparados a etapa(s)/método(s) convencionais. A utilização do catalisador da presente invenção, pentóxido de fósforo, em uma reação de ciclocondensação, proporciona a síntese de dicetopiperazina de rendimento maior e maior pureza em tempos de reação mais curtos com relação àquela(s) etapa(s)/método(s) convencionais.
[0024]A síntese convencional de dicetopiperazinas úteis em distribuição de fármacos, tal como a 2,5-diceto-3,6-di(4-fumarilaminobutil)piperazina (fumaril dicetopiperazina, FDKP), comumente começa da ciclocondensação térmica de lisina com ε-amino protegido, por exemplo (N-benziloxicarbonil)-lisina (Cbz-L-lisina) (ver FIGs. 1 e 2). A reação não catalisada é longa, 18-33 horas, com rendimentos abaixo de 50% e em alguns casos tão pequeno quanto 25%. Tais reações longas e de rendimentos relativamente baixos levam a um baixo desempenho de reator indesejável em aplicações industriais.
[0025]É compreendido que outros tenham usado pentóxido de fósforo (P2O5) como um catalisador e ácido polifosfórico como o solvente para preparar dicetopiperazinas. Por exemplo ver J. Am. Pharm. Assoc, 1957, 46:391-3, Galinsky et al. em que os autores descrevem o uso de ácido polifosfórico com P2O5 para a preparação de glicina, alanina, leucina, isoleucina e fenilalanina dicetopiperazinas; ver também ARKIVOC 2001 (ii) p. 122-134, Kappe et al. em que a síntese de diiropirimidonas de Biginelli usando P2O5 (como o éster de polifosfato) como um reagente de ciclocondensação/desidratação é descrito. Adicionalmente ver J. Org. Chem., 1961,
Petição 870180014326, de 22/02/2018, pág. 14/31
6/14
26:2534-6, Erlanger, Phosphorus pentoxide as a reagent in peptide synthesis. Descrito lá está o P2O5 (com butanol dietil hidrogeno fosfito) usado como um reagente para a preparação de um dipeptídeo linear a partir de fragmentos aminoácidos protegidos. No entanto, foi surpreendente a descoberta pelos presentes inventores que as condições de reação e solventes descritos nas referências citadas acima resultaram em degradação do material de partida (N-benziloxicarbonil)-lisina e assim foram incompatíveis com os ensinamentos da presente invenção. Assim, um catalisador que pudesse acelerar a reação e gerar maiores rendimentos foi buscado.
[0026]Uma modalidade da presente invenção inclui a incorporação de um catalisador na reação acima citada para aumentar a velocidade da reação e gerar maiores porcentagens de rendimento da presente invenção. Os três seguintes reagentes foram avaliados para suas utilidades como catalisadores como catalisadores para esta reação de ciclocondensação desidrativa: ácido sulfúrico (H2SO4), ácido fosfórico (H3PO4), e pentóxido de fósforo (P2O5) usando m-cresol como um solvente. O termo “substancialmente completo” como usado aqui como relação à síntese da presente invenção se refere a pelo menos cerca de 80% do material de partida sendo consumido dentro do período de tempo prescrito. As reações realizadas com cada um dos catalisadores potenciais. O consumo de Cbz-L-lisina e o aparecimento de bis-3,6-[(N-benziloxicarbonil)- 4-aminobutil]-2,5-dicetopiperazina (DKP1) foram monitorados por cromatografia líquida de alta performance (HPLC) em pontos de tempo através desta reação. Em pontos de tempo selecionados a DKP1 foi isolada e seu rendimento calculado.
[0027]A presença de ácido sulfúrico como um catalisador resultou em um rendimento de cerca de 35%, que está dentro da faixa de reação não catalisada. No entanto, este rendimento de 35% foi alcançado em apenas 4 horas (ver FIG. 3) quando comparado aos tempos de reação não catalisada convencionais de cerca de 18 horas a cerca 33 horas para alcançar um percentual de rendimento reacional siPetição 870180014326, de 22/02/2018, pág. 15/31
7/14 milar.
[0028]A reação catalisada por ácido fosfórico foi substancialmente completa de modo que foi consumido pelo menos cerca de 80% de Cbz-L-lisina por cerca de três horas. A DKP1 estava estável quando avaliada dentro de 4 horas da reação e o rendimento encontrado foi de cerca de 55% (ver FIG. 4).
[0029]A reação catalisada por pentóxido de fósforo consumiu cerca de 90% da Cbz-L-lisina por 1 hora e consumiu quase toda a Cbz-L-lisina por cerca de 1,5 horas. Neste ponto, o rendimento foi determinado ser cerca de 60% (ver FIG. 5). Assim, todos os três catalisadores aumentaram significativamente a velocidade da reação; e o ácido fosfórico e pentóxido de fósforo também aumentaram a porcentagem de rendimento (ver FIG. 6 e Tabela 1).
TABELA 1. Comparação da síntese de DKP1 catalisada versus não-catalisada
| Catalisador | Temperatura (°C) | Tempo (horas) | % Rendimento de DKP1 |
| Nenhum | 165 | 24-33 | 25-35 |
| H2SO4 | 165 | 4 | 35 |
| H3PO4 | 165 | 4 | 55 |
| P2O5 | 165 | 1,5 | 60 |
[0030]Solventes adequados para uso nas reações da presente invenção incluem, mas não estão limitados a m-cresol, etileno glicol, propileno glicol, tolueno, xilenos e equivalentes conhecidos para aqueles versados na referida técnica. Adicionalmente, como será evidente àqueles versados na referida técnica, vários solventes têm diferentes temperaturas de ebulição e polaridade e, portanto, as temperaturas de reação e tempos de reação podem variar entre os solventes.
EXEMPLOS
Exemplo 1
Síntese de 3,6-bis-4- (N-benziloxicarbonil) aminopropil -2,5-dicetopiperazina (DKP1) I catalisada por pentóxido de fósforo
Petição 870180014326, de 22/02/2018, pág. 16/31
8/14
[0031]Um frasco de fundo arredondado de 4 bocais 1 em L equipado com um agitador mecânico, leitura/controlador de temperatura de acoplador térmico, entrada de gás nitrogênio, e equipamento de destilação de trajeto curto foi carregado com 100g de Cbz-ornitina, 7,5g de pentóxido de fósforo, e 300 mL de m-cresol. O agitador e a purga de nitrogênio foram iniciados. A lama foi aquecida a 165°C ± 5°C. Após a formação de uma solução completa (aproximadamente 30-60 minutos), a mistura foi reservada a 165°C por um adicional de 60 minutos. A manta de aquecimento foi removida e a solução resfriada a 50°C. Uma solução têmpera foi preparada em um béquer de 2000 mL consistindo em uma mistura 80:20 de metanol:água (1000 mL). A solução reacional quente foi derramada dentro da solução agitada de metanol (MeOH) e a suspensão resultante agitada por 30 minutos. A solução foi filtrada através de um funil de vidro sinterizado de porosidade média e o bolo do filtro lavado sequencialmente com 250 mL de MeOH, 250 mL de água deionizada, e 2 x 250 mL de MeOH. O produto isolado foi seco de um dia para outro em um forno a vácuo (50°C, 30 polegadas de mercúrio). O produto bruto foi recristalizado do ácido acético e seco em um forno a vácuo para dar 58,5g (63%) da dicetopiperazina desejada.
Análise Elementar Calculada C 62,89 H 6,50 N 11,28
Encontrada C 62,15 H 6,64 N 11,09
Análise RMN 1H: (de-DMSO):
δ 8,97, 2H (NH); δ 7,28-7,37, 10H (CH); δ 7,08, 2H (NH); δ 5,01 , 4H (CHa);
Petição 870180014326, de 22/02/2018, pág. 17/31
9/14 δ 3,79, 2H (CH); δ 2,99-3,01 , 4H (CH2); δ 1,60-1,70, 4H (CHs); δ 1,46-1,57, 4H (CH2)
Exemplo 2
Síntese de DKP1 II catalisada por pentóxido de fósforo [0032]Um frasco de fundo arredondado de 1 bocal em L equipado com um agitador mecânico, equipamento de destilação de trajeto curto, leitura/controlador de temperatura de acoplador térmico, e entrada de gás nitrogênio foi carregado com Cbz-L-lisina (100g), m-cresol (200g) e pentóxido de fósforo (7,5g). A mistura reacional foi agitada, aquecida a uma temperatura alvo de 165°C, e mantida na temperatura por 1,5 horas. Ver FIG.7.
[0033]Após completado o período de aquecimento, a solução reacional foi deixada para resfriar à temperatura ambiente (22-25°C) e temperada com uma solução de água deionizada (100 mL) e MeOH (400 mL). A suspensão resultante foi agitada por 30-60 minutos e então filtrada através de um funil de vidro sinterizado de porosidade média. O bolo do filtro foi lavado sequencialmente com 250 mL de MeOH, 2 x 250 mL de água deionizada, e 2 x 250 mL de MeOH.
[0034]O bolo úmido foi seco em um forno a vácuo a 50°C. O material recuperado foi analisado por HPLC e então recristalizado do ácido acético (3 mL/grama de produto bruto) de acordo com o seguinte procedimento. A DKP1 seca bruta em ácido acético foi aquecida para refluxo em um frasco de erlenmeyer equipado com termômetro e um condensador de refluxo com cabeça de nitrogênio e saída conectada a um lavador cáustico. Após 5 a 10 minutos (para garantir que a dissolução completa ocorreu). O aquecimento foi removido e a mistura resfriada a uma temperatura menor que 100°C. Água deionizada (1 mL/grama de produto bruto) foi adicionada ao frasco e a suspensão resultante foi resfriada à temperatura ambiente com agitação por um período de 6-18 horas. O precipitado sólido foi filtrado através de um funil de vidro sinterizado de porosidade média e lavado com água deionizada (3
Petição 870180014326, de 22/02/2018, pág. 18/31
10/14 x 100 mL) e acetona (3 x 100 mL). O bolo seco recristalizado foi seco a 50°C em um forno a vácuo.
Exemplo 3
Otimização da Síntese de DKP1 catalisada por pentóxido de fósforo [0035]O acoplamento desidratante e a ciclização de Cbz-L-lisina para formar DKP1 foi avaliado como uma função do tempo de aquecimento da reação e carga de P2O5. As reações forma conduzidas usando 5%, 7,5% ou 10% de P2O5 (p/p com base na Cbl-L-lisina) com vários tempos de aquecimento (Tabela 2). Os dados indicaram que o rendimento e a pureza foram maximizados usando 7,5 % de P2O5.
[0036]Experimentos subsequentes foram projetados para identificar condições ótimas para a conversão catalisada por 7,5% de pentóxido de fósforo de CbzL-lisina a DKP1. Adicionalmente, estas reações foram monitoradas para o desaparecimento de Cbz-L-lisina. A FIG. 5 mostra dados obtidos de um estudo em que a mistura reacional Cbz-L-lisina/cresol/P2O5 (7,5%)foi monitorada para formação de DKP1 por 3 horas. durante este tempo a temperatura de reação foi mantida a 165°C ± 5°C. Alíquotas (3 mL) foram removidas em tempos especificados através da reação, temperada com água deionizada/metanol, e o produto isolado por filtração. As análises de HPLC destas amostras sugeriram que o rendimento de DKP1 alcançou um máximo após aquecimento por 1 a 3 horas (Tabela 2). Após 4 horas a 165°C ± 5°C, uma diminuição de 7-8% no rendimento de DKP1 foi observado.
[0037]Tendo identificado 1-3 horas como o tempo de reação ótimo, várias reações (escala de 100g) foram conduzidas para medir os rendimentos de DKP1 isolados dentro deste período de tempo. A FIG. 8 mostra que o rendimento isolado máximo de DKP1 (60,9%) foi obtido após 1,5 horas. As análises de HPLC mostraram ser este material >99,5% de DKP1. Esta reação foi repetida com os resultados comparados, a saber DKP1 (100% de área) foi isolado em um rendimento de 60,3%. A reação também foi conduzida usando rampas de aquecimento de 4 horas e 6 hoPetição 870180014326, de 22/02/2018, pág. 19/31
11/14 ras para simular o grande volume de tempos de aquecimento. Estas reações deram rendimentos de 59,6% e 63,1%, respectivamente (Tabela 2).
TABELA 2. Sumário de estud os de pentóxido de fósforo
| CBZ Ly (g) | %P2O5 | Período de Tempo(horas) | Temp. (°C) | Rendimento Total (%) | Pureza (% área) |
| 100 | 10,0 | 0,5 | 165 | 52,90 | 100 |
| 100 | 7,5 | 1 | 165 | 53,30 | 100 |
| 100 | 7,5 | 1,5 | 165 | 60,90 | 100 |
| 100 | 7,5 | 1,5 | 165 | 60,25 | 100 |
| 100 | 7,5 | 2 | 165 | 59,20 | 100 |
| 100 | 7,5 | 2 | 165 | 57,90 | 100 |
| 100 | 10,0 | 2 | 165 | 54,50 | 100 |
| 100 | 7,5 | 3 | 165 | 54,90 | 100 |
| 100 | 10,0 | 3 | 165 | 48,90 | 100 |
| 100 | 7,5 | 4 | 165 | 53,30 | 100 |
| 100 | 7,5 | 4 | 165 | 51,60 | 100 |
| 100 | 7,5 | 1,5* | 165 | 59,60 | 100 |
| 100 | 7,5 | 1,5** | 165 | 63,10 | 100 |
rampa de aquecimento de 4 horas **rampa de aquecimento de 6 horas [0038]As condições otimizadas (7,5% de P2O5, 165°C, 1,5 horas foram então demonstradas duas vezes na escala 5-L. Novamente uma rampa de 4 horas e 6 horas foram empregadas para simular o perfil de aquecimento empregado em volumes de produção. Ambas as reações reproduziram os resultados obtidos na escala 1L. As reações têm rendimentos totais de 58,9% e 58,4% com pureza comparável aos processos atuais (99,8%).
[0039]A menos que de outro modo indicado, todos os números expressam
Petição 870180014326, de 22/02/2018, pág. 20/31
12/14 quantidades de ingredientes, propriedades tais como peso molecular, condições reacionais e assim por diante usados no relatório descritivo e reivindicações são para serem entendidos como sendo modificados em todos os exemplos pelo termo “cerca de”. Consequentemente, a menos que indicado do contrário, os parâmetros numéricos estabelecidos no seguinte relatório descritivo e reivindicações anexadas são aproximações que podem variar dependendo das propriedades desejadas buscadas para serem obtidas pela presente invenção. No mais particular, e não como uma tentativa para limitar a aplicação da doutrina de equivalentes ao alcance das reivindicações, cada parâmetro numérico deve pelo menos estar construído à luz do número de dígitos significativos reportados e pela aplicação de técnicas de arredondamento comuns. Apesar das variações e parâmetros numéricos estabelecidos para o amplo alcance da invenção serem aproximações, os valores numéricos estabelecidos nos exemplos específicos são relatados tão precisamente quanto possíveis. Qualquer valor numérico, no entanto, inerentemente contém certos erros necessariamente resultantes do desvio padrão encontrado nas suas respectivas medidas de teste.
[0040]Os termos “um(a)” e “o(a)” e referências similares usadas no contexto de descrição da invenção (especialmente no contexto das seguintes reivindicações)são para serem construídos para cobrir tanto o singular como o plural, a menos que de outro modo indicado aqui ou claramente contraditos pelo contexto. A recitação de faixas de valores aqui é meramente pretendida para servir como um método á mão de referência individual para cada valor separado caindo dentro da faixa. A menos que de outro modo indicado aqui, cada valor individual está incorporado no relatório descritivo como se fossem individualmente citados aqui. Todos os métodos descritos aqui podem ser executados em qualquer ordem adequada, a menos que de outro modo indicado aqui ou de outro modo claramente contradito pelo contexto. O uso de qualquer ou todos os exemplos, ou linguagem exemplar, (e.g. “tal como”)
Petição 870180014326, de 22/02/2018, pág. 21/31
13/14 fornecida aqui é pretendida meramente para melhor iluminar a invenção e não impõe como uma limitação do alcance da invenção de outro modo reivindicado. Nenhuma linguagem no relatório descritivo deve ser construída como indicativo de qualquer elemento não-reivindicado essencial à prática da invenção.
[0041]Grupamentos de elementos alternativos ou modalidades da invenção revelados aqui não devem ser tomados como limitações. Cada membro do grupo pode ser referido e reivindicado individualmente ou em qualquer combinação com outros membros do grupo ou outros elementos encontrados aqui. É antecipado que um ou mais membros de um grupo podem estar incluídos em, ou deletados de, um grupo por razões de conveniência e/ou patenteabilidade. Quando qualquer de tal inclusão ou remoção ocorre, o relatório descritivo é aqui considerado para conter o grupo como modificado assim preenchendo a descrição escrita de qualquer e todos os grupos Markush usados nas reivindicações anexadas.
[0042]Modalidades preferidas desta invenção são descritas aqui, incluindo o melhor modo conhecido aos inventores para realização da invenção. Obviamente, variações naquelas modalidades preferidas se tornarão evidentes àqueles versados na referida técnica após a leitura de descrição precedente. Os inventores acreditam que os artesãos versados empreguem tais variações como apropriado, e os inventores pretendem que a invenção seja praticada de outro modo que especificamente descrito aqui. Consequentemente, a invenção inclui todas as modificações e equivalentes da matéria de estudo recitada nas reivindicações anexadas aqui como permitido pela lei aplicável. No entanto, qualquer modificação dos elementos acima descritos em todas as variações possíveis dos mesmos é alcançada pela invenção a menos que de outro modo indicado aqui ou de outro modo claramente contradito pelo contexto.
[0043]Adicionalmente, referências tem sido feitas à patentes e publicações impressas através deste relatório descritivo. Cada uma das referencias acima citaPetição 870180014326, de 22/02/2018, pág. 22/31
14/14 das e publicações impressas estão aqui individualmente incorporadas por referência em sua totalidade.
[0044]Concluindo, é para ser entendido que as modalidades da invenção revelaram aqui serem ilustrativas dos princípios da presente invenção. Outras modificações que podem ser empregadas estão dentro do alcance da invenção. Assim, por meio de exemplo, mas não de limitação, configurações alternativas da presente invenção podem ser utilizadas de acordo com os ensinamentos daqui. Consequentemente, a presente invenção não está limitada àquela precisamente como mostrado e descrito.
Petição 870180014326, de 22/02/2018, pág. 23/31
1/2
Claims (3)
1/5
Cbz-lisina
Petição 870180014326, de 22/02/2018, pág. 26/31
1. Método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina Nprotegida, CARACTERIZADO pelo fato de que compreende a etapa de aquecimento de uma solução de lisina com ε-amino protegido na presença de um catalisador selecionado do grupo que consiste em ácido sulfúrico, ácido fosfórico e pentóxido fosforoso e um solvente que consiste em m-cresol.
2/5 w
Tempo (horas@ 165oC)
Percentual de área de HPLC
Petição 870180014326, de 22/02/2018, pág. 27/31
2/2
12. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a síntese está completa dentro de 8 horas.
13. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a síntese está completa dentro de 4 horas.
14. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a síntese está completa dentro de 3 horas.
15. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a síntese está completa dentro de 1,5 hora.
16. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que o referido catalisador é pentóxido fosforoso.
17. Método, de acordo com a reivindicação 16, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 5% a 10%.
18. Método, de acordo com a reivindicação 17, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 7,5%.
19. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a lisina com ε-amino protegido é Cbz-L-lisina.
20. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que a referida síntese possui um rendimento maior do que 50%.
21. Método, de acordo com a reivindicação 20, CARACTERIZADO pelo fato de que o catalisador é pentóxido fosforoso.
22. Método, de acordo com a reivindicação 21, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 5% a 10%.
23. Método, de acordo com a reivindicação 22, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 7,5%.
24. Método, de acordo com a reivindicação 20, CARACTERIZADO pelo fato de que a lisina com ε-amino protegido é Cbz-L-lisina.
Petição 870180014326, de 22/02/2018, pág. 25/31
2. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que a lisina com ε-amino protegido é (N-benziloxicarbonil)-lisina (Cbz-L-lisina).
3. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que o catalisador é ácido sulfúrico.
4. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que o catalisador é ácido fosfórico.
5. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que o catalisador é pentóxido fosforoso.
6. Método, de acordo com a reivindicação 5, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 5% a 10%.
7. Método, de acordo com a reivindicação 6, CARACTERIZADO pelo fato de que a concentração de pentóxido fosforoso é de 7,5%.
8. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que a solução é aquecida a uma temperatura de reação de 160 oC a 170 oC.
9. Método, de acordo com a reivindicação 8, CARACTERIZADO pelo fato de que a temperatura de reação é alcançada em 4 a 6 horas.
10. Método, de acordo com a reivindicação 1, CARACTERIZADO pelo fato de que a síntese está completa dentro de cerca de 10 horas de atingimento de uma temperatura de reação.
11. Método, de acordo com a reivindicação 10, CARACTERIZADO pelo fato de que a temperatura de reação é de 160 oC a 170 oC.
Petição 870180014326, de 22/02/2018, pág. 24/31
3/5
Percentual de área de HPLC
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60334004P | 2004-08-20 | 2004-08-20 | |
| US60/603,340 | 2004-08-20 | ||
| PCT/US2005/029777 WO2006023849A2 (en) | 2004-08-20 | 2005-08-19 | Catalysis of diketopiperazine synthesis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0514263A BRPI0514263A (pt) | 2008-06-03 |
| BRPI0514263B1 true BRPI0514263B1 (pt) | 2018-05-08 |
| BRPI0514263B8 BRPI0514263B8 (pt) | 2021-05-25 |
Family
ID=35717513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514263A BRPI0514263B8 (pt) | 2004-08-20 | 2005-08-19 | método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida |
Country Status (16)
| Country | Link |
|---|---|
| US (8) | US7709639B2 (pt) |
| EP (1) | EP1786784B1 (pt) |
| JP (1) | JP5078014B2 (pt) |
| KR (1) | KR101273120B1 (pt) |
| CN (1) | CN101010305B (pt) |
| AT (1) | ATE486064T1 (pt) |
| AU (1) | AU2005277208B2 (pt) |
| BR (1) | BRPI0514263B8 (pt) |
| CA (1) | CA2575692C (pt) |
| DE (1) | DE602005024413D1 (pt) |
| DK (1) | DK1786784T3 (pt) |
| ES (1) | ES2385934T3 (pt) |
| IL (2) | IL181091A (pt) |
| MX (1) | MX2007001903A (pt) |
| PL (1) | PL1786784T3 (pt) |
| WO (1) | WO2006023849A2 (pt) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| ES2395096T3 (es) | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
| JP3952293B2 (ja) * | 2003-01-06 | 2007-08-01 | ソニー株式会社 | 指紋照合装置および方法、記録媒体、並びに、プログラム |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| KR101530050B1 (ko) | 2007-03-02 | 2015-06-22 | 주식회사 노브메타파마 | 알츠하이머 질환 및 치매를 치료하기 위한 조성물 및 방법 |
| KR20100090692A (ko) * | 2007-10-24 | 2010-08-16 | 맨카인드 코포레이션 | 활성제의 전달 |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| KR101736502B1 (ko) | 2007-10-24 | 2017-05-16 | 맨카인드 코포레이션 | Glp-1에 의한 유해 효과의 예방 방법 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| SG10201403147SA (en) | 2009-06-12 | 2014-10-30 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
| RU2673525C2 (ru) | 2009-11-02 | 2018-11-27 | Мэннкайнд Корпорэйшн | Способ для производства микрочастиц соединения |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| US9140651B2 (en) | 2010-05-07 | 2015-09-22 | Mannkind Corporation | Determining percent solids in suspension using raman spectroscopy |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| KR101278140B1 (ko) * | 2010-07-15 | 2013-06-27 | 공주대학교 산학협력단 | 2,5-다이케토피페라진 유도체를 활성성분으로 포함하는 농업용 약제 |
| EP2673265B1 (en) * | 2011-02-10 | 2016-10-19 | MannKind Corporation | Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| CN108014340A (zh) | 2011-04-12 | 2018-05-11 | 莫伊莱麦屈克斯公司 | 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| WO2013142969A1 (en) * | 2012-03-28 | 2013-10-03 | Jian Ping Gao | Urethanes and ureas and processes |
| BR112014026809A2 (pt) | 2012-04-27 | 2017-06-27 | Mannkind Corp | métodos para a síntese de etilfumaratos ativados e seu uso como intermediários |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| US8962836B2 (en) * | 2013-03-15 | 2015-02-24 | Mannkind Corporation | Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| MX2017006372A (es) | 2014-11-17 | 2017-08-21 | Moerae Matrix Inc | Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matrix extracelular. |
| CA2978941A1 (en) | 2015-03-12 | 2016-09-15 | Moerae Matrix, Inc. | Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same |
| IL260823B2 (en) | 2016-01-29 | 2024-08-01 | Mannkind Corp | Dry powder inhaler |
| TW201809049A (zh) | 2016-03-31 | 2018-03-16 | 盧伯利索先進材料有限公司 | 生物可分解及/或生物可吸收的熱塑性聚胺甲酸酯 |
| CN118994038B (zh) * | 2024-07-31 | 2025-09-26 | 三峡大学 | 一种甘氨酸合成甘氨酸酐的方法 |
Family Cites Families (1083)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB475440A (en) | 1935-09-23 | 1937-11-19 | Mine Safety Appliances Co | Improvements in or relating to apparatus for determining the flow resistance of breathing apparatus elements |
| US2549303A (en) | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
| BE509861A (pt) | 1952-03-13 | |||
| US2754276A (en) | 1953-02-12 | 1956-07-10 | Du Pont | Cellular compositions utilizing dinitrosopentamethylene-tetramine as the blowing agent |
| US3337740A (en) | 1962-02-13 | 1967-08-22 | Deering Milliken Res Corp | Process for separating acrylic acid from impurities |
| US4187129A (en) | 1962-05-14 | 1980-02-05 | Aerojet-General Corporation | Gelled mechanically stable high energy fuel composition containing metal platelets |
| FR1451293A (fr) | 1964-05-18 | 1966-01-07 | Entoleter | Matière composite et son procédé de préparation |
| US3407203A (en) | 1965-03-22 | 1968-10-22 | Union Carbide Corp | Novel process for the preparation of diketopiperazines |
| US3669113A (en) | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device |
| US3518340A (en) | 1968-04-15 | 1970-06-30 | Dow Corning | Method of forming silicone rubber drug carriers |
| US3622053A (en) | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
| US3673698A (en) | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
| BE794951A (fr) | 1972-02-03 | 1973-05-29 | Parke Davis & Co | Conditionnement soluble dans l'eau |
| US3873651A (en) | 1972-05-12 | 1975-03-25 | Atomic Energy Commission | Freeze drying method for preparing radiation source material |
| US3823843A (en) | 1972-10-26 | 1974-07-16 | Lilly Co Eli | Locking capsule |
| US3856142A (en) | 1973-01-24 | 1974-12-24 | Mine Safety Appliances Co | Inhalant package |
| FR2224175B1 (pt) | 1973-04-04 | 1978-04-14 | Isf Spa | |
| US3980074A (en) | 1973-07-18 | 1976-09-14 | Beecham Group Limited | Device for the administration of powders |
| GB1479283A (en) | 1973-07-23 | 1977-07-13 | Bespak Industries Ltd | Inhaler for powdered medicament |
| GB1459488A (en) | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
| IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
| US4018619A (en) | 1974-09-23 | 1977-04-19 | Iu Technology Corporation | Highly activated mixtures for constructing load bearing surfaces and method of making the same |
| US4005711A (en) | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
| DE2502251A1 (de) | 1975-01-17 | 1976-07-22 | Schering Ag | Vorrichtung zur inhalation pulverfoermiger feststoffe |
| US4040536A (en) | 1975-05-05 | 1977-08-09 | R. P. Scherer Corporation | Locking hard gelatin capsule |
| BR7603665A (pt) | 1975-06-09 | 1977-02-01 | Nat Distillers Chem Corp | Processo para comunicar resistencia a aglomeracao a um polimero de etileno-acetano de vinila e o polimero resultant |
| US4153689A (en) | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
| US3998226A (en) | 1975-09-22 | 1976-12-21 | Edward G. Gomez | Inhalation device for encapsulated concentrates |
| GB1509979A (en) | 1975-11-28 | 1978-05-10 | Fisons Ltd | Pharmaceutical compositions containing aspirin or indomethacin |
| US4102953A (en) | 1976-05-25 | 1978-07-25 | The United States Of America As Represented By The Secretary Of The Navy | Method for making extruded, solventless, composite-modified double base propellant |
| USD252707S (en) | 1977-01-03 | 1979-08-21 | Joel Besnard | Inhaler |
| GB1598081A (en) | 1977-02-10 | 1981-09-16 | Allen & Hanburys Ltd | Inhaler device for dispensing medicaments |
| US4171000A (en) | 1977-03-23 | 1979-10-16 | Uhle Klaus P | Smoking device |
| IE46865B1 (en) | 1977-04-29 | 1983-10-19 | Allen & Hanburys Ltd | Device for dispensing medicaments |
| US4148308A (en) | 1977-05-31 | 1979-04-10 | Sayer William J | Mouthpiece with a tongue retractor |
| US4110240A (en) | 1977-07-29 | 1978-08-29 | Wyrough And Loser, Inc. | Coprecipitation process |
| US4091077A (en) | 1977-08-12 | 1978-05-23 | The United States Of America As Represented By The United States Department Of Energy | Process for recovering filler from polymer |
| US4211769A (en) | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
| US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
| CA1113044A (en) | 1977-12-16 | 1981-11-24 | J. Paul Leblond | Personal repellant device |
| US4356167A (en) | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
| US4175556A (en) | 1978-04-07 | 1979-11-27 | Freezer Winthrop J | Inhaler with flow-through cap |
| US4196196A (en) | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| US4168002A (en) | 1978-08-03 | 1979-09-18 | Crosby Leslie O | Multiple-seed package card |
| US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
| DE2840442C2 (de) | 1978-09-16 | 1982-02-11 | C.H. Boehringer Sohn, 6507 Ingelheim | Verwendung des Diketopiperazins L-Leu-L-Trp als Geschmacksstoff für Getränke mit bitterer Geschmacksrichtung |
| DE2849493C2 (de) | 1978-11-15 | 1982-01-14 | Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems | In der Hand zu haltender Aerosolspender |
| USD269463S (en) | 1978-12-08 | 1983-06-21 | Fisons Limited | Container for a medicinal inhaler |
| JPS5837833Y2 (ja) | 1979-04-27 | 1983-08-26 | 凸版印刷株式会社 | アンプル収納容器 |
| JPS6034925B2 (ja) | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
| US4407525A (en) | 1979-10-04 | 1983-10-04 | Gao Gesellschaft Fur Automation Und Organisation Mbh | Identification card with hallmark for authentication by incident and transmitted light |
| GB2072536B (en) | 1980-03-25 | 1983-12-07 | Malem H | Nebuliser |
| US4289759A (en) | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
| DE3167658D1 (en) | 1980-12-12 | 1985-01-17 | Combi Co | Inhaler |
| US4900730A (en) | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
| GB2092136B (en) | 1981-01-17 | 1985-06-05 | Mitsui Toatsu Chemicals | Production of n-substituted amide compounds |
| JPS58140026A (ja) | 1982-01-14 | 1983-08-19 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
| IT1220979B (it) | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | Capsule contenenti un allergene e procedimento per la loro preparazione |
| EP0069715B1 (en) | 1981-07-08 | 1986-11-05 | Aktiebolaget Draco | Powder inhalator |
| SE438261B (sv) | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
| US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
| USD276654S (en) | 1981-09-15 | 1984-12-04 | Aktiebolaget Draco | Medical aerosol inhalation device |
| KR890000664B1 (ko) | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| US4659696A (en) | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| US4483922A (en) | 1982-05-14 | 1984-11-20 | Amf Inc. | Inactivation of enzymes |
| US4526804A (en) | 1982-08-30 | 1985-07-02 | Ball Corporation | Method for providing sheet metal stock with finely divided powder |
| US4487327A (en) | 1982-12-21 | 1984-12-11 | Grayson Robert E | Locking capsule |
| JPS59163313A (ja) | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| US4481139A (en) | 1983-04-13 | 1984-11-06 | Board Of Regents, The University Of Texas System | Peptide antagonists of substance P |
| AU90762S (en) | 1983-06-29 | 1985-08-15 | Glaxo Group Ltd | Inhaler |
| US4581020A (en) | 1983-07-18 | 1986-04-08 | Trimedyne, Inc. | Medication delivery device and system for percutaneous administration of medication |
| GB8325529D0 (en) | 1983-09-23 | 1983-10-26 | Lilly Industries Ltd | Medicinal forms |
| CH661878A5 (de) | 1983-11-04 | 1987-08-31 | Warner Lambert Co | Kapsel-dosierungsformen. |
| US4671954A (en) | 1983-12-13 | 1987-06-09 | University Of Florida | Microspheres for incorporation of therapeutic substances and methods of preparation thereof |
| USD295321S (en) | 1984-03-13 | 1988-04-19 | Glaxo Group Limited | Inhaler container for a medical aerosol |
| JPS60248618A (ja) | 1984-05-24 | 1985-12-09 | Nippon Zoki Pharmaceut Co Ltd | ジペプチドを含有する潰瘍治療剤 |
| US4927555A (en) | 1984-08-13 | 1990-05-22 | Colgate-Palmolive Company | Process for making thixotropic detergent compositions |
| USD288852S (en) | 1984-08-29 | 1987-03-17 | Aruman Co., Ltd. | Disposable inhaler |
| US4757066A (en) | 1984-10-15 | 1988-07-12 | Sankyo Company Limited | Composition containing a penem or carbapenem antibiotic and the use of the same |
| IE58468B1 (en) | 1984-10-25 | 1993-09-22 | Warner Lambert Co | Method for sealing capsules and capsule |
| US4592348A (en) | 1984-12-17 | 1986-06-03 | Waters Iv William C | Aerosol inhaler |
| US4946828A (en) | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
| SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
| JPS6320301Y2 (pt) | 1985-04-18 | 1988-06-06 | ||
| US5785989A (en) | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
| US4615817A (en) | 1985-05-17 | 1986-10-07 | Mccoy Frederic C | Additives containing polytetrafluoroethylene for making stable lubricants |
| CA1318730C (en) | 1985-05-30 | 1993-06-01 | C. Edward Capes | Method of separating carbonaceous components from particulate coal containing inorganic solids and apparatus therefor |
| US5098590A (en) | 1988-02-04 | 1992-03-24 | Colgate Palmolive Co. | Thixotropic aqueous automatic dishwasher detergent compositions with improved stability |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| AT384552B (de) | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft |
| US4624861A (en) | 1985-09-05 | 1986-11-25 | Gte Products Corporation | Rare earth oxysulfide phosphors and processes for creating same |
| US4742156A (en) | 1985-09-30 | 1988-05-03 | Mcneilab, Inc. | Peptide antagonists of neurokinin B and opthalmic solutions containing them |
| PT83613B (en) | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
| EP0248051A1 (en) | 1985-11-29 | 1987-12-09 | FISONS plc | Pharmaceutical composition including sodium cromoglycate |
| LU86258A1 (fr) | 1986-01-21 | 1987-09-03 | Rech Dermatologiques C I R D S | Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
| US4849227A (en) | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
| US5120712A (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| US4926852B1 (en) | 1986-06-23 | 1995-05-23 | Univ Johns Hopkins | Medication delivery system phase one |
| USD301273S (en) | 1986-07-10 | 1989-05-23 | Leonard G Darin | Hand held fly suction device |
| JPS6320301A (ja) | 1986-07-11 | 1988-01-28 | Dainichi Color & Chem Mfg Co Ltd | キトサン微小粒体 |
| US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
| ES2053549T3 (es) | 1986-08-11 | 1994-08-01 | Innovata Biomed Ltd | Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion. |
| US4925673A (en) | 1986-08-18 | 1990-05-15 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
| USRE35862E (en) | 1986-08-18 | 1998-07-28 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
| ES2032831T5 (es) | 1986-08-19 | 2001-02-16 | Genentech Inc | Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas. |
| DE3639836A1 (de) | 1986-11-21 | 1988-06-01 | Sigrid Bechter | Mundstueck fuer ein inhalationsgeraet |
| KR890003520Y1 (ko) | 1986-12-20 | 1989-05-27 | 주식회사 서흥캅셀 | 의약용 캅셀 |
| US4861627A (en) | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
| US4981295A (en) | 1987-05-11 | 1991-01-01 | City Of Hope | Respiratory training using feedback |
| US6645504B1 (en) | 1987-06-24 | 2003-11-11 | Autoimmune Inc. | Bystander suppression of type I diabetes by oral administration of glucagon |
| DE3727894A1 (de) | 1987-08-21 | 1989-03-02 | Stephan Dieter | Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge |
| GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
| US4887722A (en) | 1987-12-11 | 1989-12-19 | Greenward Sr Edward H | Method for beneficiating by carbonaceous refuse |
| DE3801326A1 (de) | 1988-01-19 | 1989-07-27 | Asea Brown Boveri | Verfahren zur herstellung einer keramiksuspension |
| US4981625A (en) | 1988-03-14 | 1991-01-01 | California Institute Of Technology | Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops |
| GB8813338D0 (en) | 1988-06-06 | 1988-07-13 | Osprey Metals Ltd | Powder production |
| USD316902S (en) | 1988-09-02 | 1991-05-14 | Hoelfing H Curt | Meter hose inhaler reservoir |
| GB8821287D0 (en) | 1988-09-12 | 1988-10-12 | Ici Plc | Device |
| EP0360340A1 (en) | 1988-09-19 | 1990-03-28 | Akzo N.V. | Composition for nasal administration containing a peptide |
| USD321570S (en) | 1988-09-30 | 1991-11-12 | Blasdell Richard J | Inhaler |
| ATE104867T1 (de) | 1988-10-04 | 1994-05-15 | Univ Johns Hopkins | Inhalationsgeraet fuer aerosolen. |
| JPH02104531A (ja) | 1988-10-14 | 1990-04-17 | Toyo Jozo Co Ltd | 経鼻投与用生理活性ペプチド組成物 |
| US4984158A (en) | 1988-10-14 | 1991-01-08 | Hillsman Dean | Metered dose inhaler biofeedback training and evaluation system |
| JPH02115154A (ja) | 1988-10-25 | 1990-04-27 | Kao Corp | イミド化合物及びその用途 |
| USD326517S (en) | 1988-10-27 | 1992-05-26 | Glaxo Group Limited | Inhalator |
| JP2692742B2 (ja) | 1988-11-30 | 1997-12-17 | 株式会社ツムラ | 新規なリグナン類 |
| US5006343A (en) | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
| US5075027A (en) | 1989-02-06 | 1991-12-24 | Colgate Palmolive Co. | Thixotropic aqueous scented automatic dishwasher detergent compositions |
| US5514646A (en) | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| IT1228460B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore monouso con capsula pre-forata |
| US4983402A (en) | 1989-02-24 | 1991-01-08 | Clinical Technologies Associates, Inc. | Orally administerable ANF |
| SE466684B (sv) | 1989-03-07 | 1992-03-23 | Draco Ab | Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator |
| US5358734A (en) | 1989-03-30 | 1994-10-25 | Gte Products Corporation | Process for producing a blue emitting lamp phosphor |
| US5215739A (en) | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
| US5067500A (en) | 1989-04-24 | 1991-11-26 | Philip Morris Incorporated | Container for additive materials for smoking articles |
| US4991605A (en) | 1989-04-24 | 1991-02-12 | Philip Morris Incorporated | Container for additive materials for smoking articles |
| JPH05501505A (ja) | 1989-04-28 | 1993-03-25 | ライカー ラボラトリーズ,インコーポレイティド | 乾燥粉末吸入装置 |
| GB8909891D0 (en) | 1989-04-28 | 1989-06-14 | Riker Laboratories Inc | Device |
| ATE99546T1 (de) | 1989-05-01 | 1994-01-15 | Alkermes Inc | Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen. |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US5017383A (en) | 1989-08-22 | 1991-05-21 | Taisho Pharmaceutical Co., Ltd. | Method of producing fine coated pharmaceutical preparation |
| GB8919131D0 (en) | 1989-08-23 | 1989-10-04 | Riker Laboratories Inc | Inhaler |
| US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
| GB8921222D0 (en) | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
| DK544589D0 (da) | 1989-11-01 | 1989-11-01 | Novo Nordisk As | Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof |
| JPH0741428Y2 (ja) | 1989-11-04 | 1995-09-27 | アップリカ葛西株式会社 | ベビーバス |
| CA2071867A1 (en) | 1989-11-06 | 1991-05-07 | Edith Mathiowitz | Method for producing protein microspheres |
| US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| US5105291A (en) | 1989-11-20 | 1992-04-14 | Ricoh Company, Ltd. | Liquid crystal display cell with electrodes of substantially amorphous metal oxide having low resistivity |
| AU6774790A (en) | 1989-12-06 | 1991-06-13 | Canon Kabushiki Kaisha | Package for ink jet cartridge |
| USD331106S (en) | 1989-12-30 | 1992-11-17 | Ing. Erich Pfeiffer Gmbh & Co. Kg | Single use inhaler |
| GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| US5545618A (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
| US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
| SK280968B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Balenie medikamentu na použite v inhalačnom prístroji |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| MY105368A (en) | 1990-03-02 | 1994-09-30 | Glaxo Group Ltd | Inhalation device. |
| US5615670A (en) | 1990-03-07 | 1997-04-01 | Fisons Plc | Powder inhaler with centrifugal force used to meter powder |
| IT1240750B (it) | 1990-04-12 | 1993-12-17 | Chiesi Farma Spa | Dispositivo per la somministrazione di sostanze medicamentose in polvere |
| JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US5328464A (en) | 1990-04-24 | 1994-07-12 | Science Incorporated | Closed drug delivery system |
| USD338268S (en) | 1990-05-04 | 1993-08-10 | Omron Corporation | Heating inhaler |
| EP0527940A1 (en) | 1990-05-08 | 1993-02-24 | Liposome Technology, Inc. | Direct spray-dried drug/lipid powder composition |
| IL111254A (en) | 1990-06-14 | 1998-10-30 | Rhone Poulenc Rorer Ltd | Powder inhalers |
| DE4021263C2 (de) | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
| US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
| US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US5443841A (en) | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
| US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
| US5451410A (en) | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
| US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5541155A (en) | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
| JPH04103585A (ja) | 1990-08-24 | 1992-04-06 | Nisshin Flour Milling Co Ltd | ピロリジン環を有する化合物 |
| US5074418A (en) | 1990-09-12 | 1991-12-24 | Pitney Bowes Inc. | Ink replenishing system transport and storage container |
| SE9002895D0 (sv) | 1990-09-12 | 1990-09-12 | Astra Ab | Inhalation devices for dispensing powders i |
| DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie B.V., Haarlem | Wirbelkammer-Pulverinhalator |
| US5170801A (en) | 1990-10-02 | 1992-12-15 | Glaxo Inc. | Medical capsule device actuated by radio-frequency (rf) signal |
| FR2667509B1 (fr) | 1990-10-04 | 1995-08-25 | Valois | Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes. |
| IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
| GB9024760D0 (en) | 1990-11-14 | 1991-01-02 | Riker Laboratories Inc | Inhalation device and medicament carrier |
| US5124291A (en) | 1990-11-15 | 1992-06-23 | The Standard Oil Company | Method for deagglomerating and re-exposing catalyst in a fluid bed reactor |
| GB9026191D0 (en) | 1990-12-01 | 1991-01-16 | Harris Pharma Ltd | Breath actuated dispensing device |
| GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
| EP0563120B1 (en) | 1990-12-17 | 1997-10-01 | Minnesota Mining And Manufacturing Company | Inhaler |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| GB2253200A (en) | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
| WO1992014449A1 (en) | 1991-02-20 | 1992-09-03 | Nova Pharmaceutical Corporation | Controlled release microparticulate delivery system for proteins |
| US5208998A (en) | 1991-02-25 | 1993-05-11 | Oyler Jr James R | Liquid substances freeze-drying systems and methods |
| US5394866A (en) | 1991-03-05 | 1995-03-07 | Aradigm Corporation | Automatic aerosol medication delivery system and methods |
| WO1994016758A1 (en) | 1991-03-05 | 1994-08-04 | Miris Medical Corporation | A medication cassette for an automatic aerosol medication delivery system |
| US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
| USD338062S (en) | 1991-03-06 | 1993-08-03 | Innovata Biomed Limited | Inhaler |
| USD347057S (en) | 1991-03-14 | 1994-05-17 | Technosystem Limited | Inhaler |
| US5797391A (en) | 1991-03-28 | 1998-08-25 | Rhone-Poulenc Rorer Limited | Inhaler |
| US5413804A (en) | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
| US5244653A (en) | 1991-05-01 | 1993-09-14 | Isp Chemicals Inc. | Glycine anhydride dimethylol as a biocide and preservative |
| US6055980A (en) | 1991-05-20 | 2000-05-02 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US6060069A (en) | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
| US5492112A (en) | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5327883A (en) | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
| FR2676929B1 (fr) | 1991-05-30 | 1994-02-11 | Aerosols Bouchage Ste Fse | Inhalateur de poudres. |
| CA2070061C (en) | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
| IT1248059B (it) | 1991-06-14 | 1995-01-05 | Miat Spa | Insufflatore multidose per farmaci in polvere |
| ES2141108T3 (es) | 1991-07-02 | 2000-03-16 | Inhale Inc | Metodo y dispositivo para proporcionar medicamentos en aerosol. |
| US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
| US5203768A (en) | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
| US5337740A (en) | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
| GB9116610D0 (en) | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
| US5139878A (en) | 1991-08-12 | 1992-08-18 | Allied-Signal Inc. | Multilayer film constructions |
| ATE139130T1 (de) | 1991-08-16 | 1996-06-15 | Sandoz Ag | Inhalator zur verabreichung von pulverförmigen substanzen |
| US5287850A (en) | 1991-08-20 | 1994-02-22 | Habley Medical Technology Corporation | Timing and velocity controlled powered pharmaceutical inhaler |
| US6029661A (en) | 1991-08-26 | 2000-02-29 | 3M Innovative Properties Company | Powder dispenser |
| USD337636S (en) | 1991-09-12 | 1993-07-20 | Devilbiss Health Care, Inc. | Ultrasonic medicament nebulizer |
| US5167506A (en) | 1991-10-24 | 1992-12-01 | Minnesota Mining And Manufacturing Company | Inhalation device training system |
| USD348100S (en) | 1991-10-29 | 1994-06-21 | Fisons Plc | Medicament inhaler |
| USD350602S (en) | 1991-11-01 | 1994-09-13 | Rhone-Poulenc Rorer Limited | Combined dry powder inhaler and cap |
| US6063910A (en) | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
| USD350821S (en) | 1991-11-18 | 1994-09-20 | Smithkline Beecham P.L.C. | Oral inhaler |
| SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
| USD340975S (en) | 1991-12-02 | 1993-11-02 | Thayer Medical Corporation | Combined expansion chamber metered dose inhaler dispenser and adaptor |
| US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| DE4211475A1 (de) | 1991-12-14 | 1993-06-17 | Asta Medica Ag | Pulverinhalator |
| JP3121080B2 (ja) | 1991-12-19 | 2000-12-25 | アール・ピー・シーラー コーポレイション | カプセル封入用溶液 |
| GB2262452B (en) | 1991-12-19 | 1995-12-20 | Minnesota Mining & Mfg | Inhalation device |
| US5363842A (en) | 1991-12-20 | 1994-11-15 | Circadian, Inc. | Intelligent inhaler providing feedback to both patient and medical professional |
| US5525519A (en) | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
| US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
| CA2127877A1 (en) | 1992-01-21 | 1993-07-22 | Robert M. Platz | Improved process for preparing micronized polypeptide drugs |
| DE9209050U1 (de) | 1992-02-13 | 1992-10-01 | Schrader, Barthold von, 2400 Travemünde | Inhalationseinrichtung |
| US5476093A (en) | 1992-02-14 | 1995-12-19 | Huhtamaki Oy | Device for more effective pulverization of a powdered inhalation medicament |
| US5469971A (en) | 1992-02-26 | 1995-11-28 | Estee Lauder Inc. | Method and apparatus for deagglomerating powder |
| EP0558879B1 (en) | 1992-03-04 | 1997-05-14 | Astra Aktiebolag | Disposable inhaler |
| US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
| US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| DK36392D0 (da) | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Anvendelse af kemisk forbindelse |
| USD348929S (en) | 1992-04-03 | 1994-07-19 | Norton Healthcare Limited | Medicament inhaler |
| CA2096302A1 (en) | 1992-05-15 | 1993-11-16 | David Kilis | Air flow controller and recording system |
| USD350193S (en) | 1992-06-11 | 1994-08-30 | Schering Corporation | Combined inhaler and cover |
| USD344796S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
| USD344797S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
| USD345013S (en) | 1992-06-11 | 1994-03-08 | Schering Corporation | Combined inhaler and cover |
| WO1993025193A1 (fr) | 1992-06-12 | 1993-12-23 | Teijin Limited | Preparation pharmaceutique destinee a etre administree par les voies respiratoires |
| US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
| US5811127A (en) | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US5394868A (en) | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
| GB9213874D0 (en) | 1992-06-30 | 1992-08-12 | Fisons Plc | Process to novel medicament form |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| GB9214819D0 (en) | 1992-07-13 | 1992-08-26 | Minnesota Mining & Mfg | Valve assemblies |
| GB9216038D0 (en) | 1992-07-28 | 1992-09-09 | Bespak Plc | Dispensing apparatus for powdered medicaments |
| GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
| US5239993A (en) | 1992-08-26 | 1993-08-31 | Glaxo Inc. | Dosage inhalator providing optimized compound inhalation trajectory |
| GB2270293A (en) | 1992-09-05 | 1994-03-09 | Medix Ltd | Drug dispensing system |
| USD348928S (en) | 1992-09-21 | 1994-07-19 | Schering Corporation | Inhaler |
| US5333106A (en) | 1992-10-09 | 1994-07-26 | Circadian, Inc. | Apparatus and visual display method for training in the power use of aerosol pharmaceutical inhalers |
| WO1994008599A1 (en) | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| DE69322789T2 (de) | 1992-10-19 | 1999-07-01 | Dura Pharmaceuticals, Inc., San Diego, Calif. | Trockenpulverinhalator |
| AU121578S (en) | 1992-10-22 | 1994-09-20 | Fisons Plc | An inhalation device |
| USD359555S (en) | 1992-11-18 | 1995-06-20 | Nippon Glaxo Limited | Nasal medicine inhaler |
| USD349572S (en) | 1992-12-10 | 1994-08-09 | Schering Corporation | Aerosol inhaler |
| USD352107S (en) | 1992-12-10 | 1994-11-01 | Ciba-Geigy Corporation | Inhaler |
| SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
| US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
| JP2924924B2 (ja) | 1992-12-18 | 1999-07-26 | シェリング・コーポレーション | 粉末薬物のための吸入器 |
| US5401516A (en) | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
| US6105571A (en) | 1992-12-22 | 2000-08-22 | Electrosols, Ltd. | Dispensing device |
| US6880554B1 (en) | 1992-12-22 | 2005-04-19 | Battelle Memorial Institute | Dispensing device |
| US5896855A (en) | 1992-12-24 | 1999-04-27 | Rhone-Poulenc Rorer Limited | Multi dose inhaler apparatus |
| FR2700279B1 (fr) | 1993-01-14 | 1995-03-17 | Valois | Dispositif portatif pour projeter des doses d'une substance fluide à l'aide d'un flux d'air comprimé. |
| AU119600S (en) | 1993-01-21 | 1994-03-07 | Boehringer Ingelheim Kg | Inhaler device |
| US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
| US5888477A (en) | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US6131567A (en) | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
| US5364838A (en) | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
| US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
| IL108780A (en) | 1993-02-27 | 1999-06-20 | Fisons Plc | Inhalation device |
| US5437271A (en) | 1993-04-06 | 1995-08-01 | Minnesota Mining And Manufacturing Company | Deagglomerators for dry powder inhalers |
| US5372128A (en) | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
| ZA939608B (en) | 1993-04-22 | 1994-08-24 | Emisphere Tech Inc | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof. |
| IL109403A0 (en) | 1993-04-22 | 1994-07-31 | Emisphere Tech Inc | Oral drug delivery compositions and methods |
| US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5360614A (en) | 1993-04-26 | 1994-11-01 | The Estee Corporation | Method of controlling the release of carbohydrates by encapsulation and composition therefor |
| EP0695171B1 (en) | 1993-04-28 | 1996-12-18 | Akzo Nobel N.V. | Lyospheres comprising gonadotropin |
| DK0652022T3 (da) | 1993-05-12 | 1999-09-13 | Teijin Ltd | Indretning og fremgangsmåde til afgivelse af flere doser pulverformig medicin |
| US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| US5533502A (en) | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
| USD365876S (en) | 1993-06-16 | 1996-01-02 | Chawla Brindra P S | Medicament inhaler |
| US5747445A (en) | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
| TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
| GB9314614D0 (en) | 1993-07-14 | 1993-08-25 | Minnesota Mining & Mfg | Dry powder inhalers |
| US5371046A (en) | 1993-07-22 | 1994-12-06 | Taiwan Semiconductor Manufacturing Company | Method to solve sog non-uniformity in the VLSI process |
| JPH0741428A (ja) | 1993-07-30 | 1995-02-10 | Teijin Ltd | ペプチド、蛋白質性薬物経鼻・経肺製剤 |
| US5306453A (en) | 1993-08-18 | 1994-04-26 | Edward Shulman | Apparatus and method of making a non-woven fabric |
| JP3545764B2 (ja) | 1993-08-18 | 2004-07-21 | フアイソンズ・ピーエルシー | 吸息率制御器を備えた吸入装置 |
| US5524613A (en) | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
| BE1007551A3 (nl) | 1993-09-24 | 1995-08-01 | Philips Electronics Nv | Werkwijze voor het in een rekenmachine automatisch herstellen van consistentie in een hierarchische objektstruktuur na een interaktie door een gebruiker en rekenmachine voorzien van zo een systeem voor automatische consistentieherstelling. |
| US5477285A (en) | 1993-10-06 | 1995-12-19 | Thomson Consumer Electronics, Inc. | CRT developing apparatus |
| GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| US5726156A (en) | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| HUT75162A (en) | 1993-11-16 | 1997-04-28 | Depotech Corp | Vesicles with controlled release of actives |
| EP0655237A1 (de) | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Medizinische Aerosolformulierung |
| USD358880S (en) | 1993-12-02 | 1995-05-30 | Tenax Corporation | Dry powder inhalator |
| US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
| DE4422710C1 (de) | 1994-06-29 | 1995-09-14 | Boehringer Ingelheim Kg | Inhalationsgerät mit einem Elektronikmodul zur Funktionsüberwachung |
| WO1995016483A1 (en) | 1993-12-18 | 1995-06-22 | Merck Patent Gmbh | Powder inhalator |
| USD357603S (en) | 1993-12-20 | 1995-04-25 | Wolff Stephen H | Base for displaying or holding items |
| US5415162A (en) | 1994-01-18 | 1995-05-16 | Glaxo Inc. | Multi-dose dry powder inhalation device |
| US5484606A (en) | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
| PT101450B (pt) | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
| JPH09508695A (ja) | 1994-02-09 | 1997-09-02 | キナートン・リミテッド | 溶液から材料を乾燥する方法 |
| SE9400462D0 (sv) | 1994-02-11 | 1994-02-11 | Astra Ab | Filling device |
| DE69535897D1 (de) | 1994-03-07 | 2009-01-22 | Nektar Therapeutics | Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| US5505194A (en) | 1994-03-23 | 1996-04-09 | Abbott Laboratories | Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions |
| US5839429A (en) | 1994-03-25 | 1998-11-24 | Astra Aktiebolag | Method and apparatus in connection with an inhaler |
| AU124387S (en) | 1994-03-25 | 1995-08-11 | Astra Ab | Training device for an inhaler |
| DE59500494D1 (de) | 1994-04-15 | 1997-09-18 | Fissler Gmbh | Gar- und/oder Kochgerät, welches für eine bodenseitige Zuführung von Wärmeenergie durch Wärmeleitung oder durch elektromagnetische Induktion eingerichtet ist |
| US6395744B1 (en) | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
| FI942196L (fi) | 1994-05-11 | 1995-11-12 | Orion Yhtymae Oy | Jauheinhalaattori |
| AU696387B2 (en) | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
| AU2517095A (en) | 1994-05-19 | 1995-12-18 | R.P. Scherer International Corporation | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
| JP3372105B2 (ja) | 1994-05-26 | 2003-01-27 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| US5483954A (en) | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
| IL110024A (en) | 1994-06-15 | 1998-04-05 | Yissum Res Dev Co | Controlled release oral drug delivery system containing hydrogel- forming polymer |
| USD363775S (en) | 1994-06-21 | 1995-10-31 | Rhone-Poulenc Rorer Limited | Multidose dry powder inhaler |
| USD362500S (en) | 1994-06-28 | 1995-09-19 | Thayer Medical Corporation | Medication inhaler spacer |
| US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
| US6039208A (en) | 1994-07-29 | 2000-03-21 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
| US5562231A (en) | 1994-07-29 | 1996-10-08 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
| US5623724A (en) | 1994-08-09 | 1997-04-22 | Northrop Grumman Corporation | High power capacitor |
| GB9416884D0 (en) | 1994-08-20 | 1994-10-12 | Danbiosyst Uk | Drug delivery compositions |
| USD359153S (en) | 1994-08-25 | 1995-06-13 | Viggiano Bernard J | Muffin top |
| US5574008A (en) | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
| US5547929A (en) | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
| ATE387925T1 (de) | 1994-09-21 | 2008-03-15 | Nektar Therapeutics | Vorrichtung und verfahren zum dispergieren von trockenen pulvermedikamenten |
| FR2725626A1 (fr) | 1994-10-18 | 1996-04-19 | Sofab | Dispositif pour l'inhalation de produits en poudre |
| WO1996013250A1 (en) | 1994-10-27 | 1996-05-09 | Amgem Inc. | Compositions for increased bioavailability of orally delivered therapeutic agents |
| SE9404140D0 (sv) | 1994-11-29 | 1994-11-29 | Astra Ab | Dose indicating device |
| AU691361B2 (en) | 1994-12-01 | 1998-05-14 | Toyama Chemical Co. Ltd. | Novel 2,3-diketopiperazine derivative or salt thereof |
| SE9404439D0 (sv) | 1994-12-21 | 1994-12-21 | Astra Ab | Inhalation device |
| SA95160463B1 (ar) | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
| US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
| AU693306B2 (en) | 1995-01-23 | 1998-06-25 | Direct-Haler A/S | An inhaler |
| USD368364S (en) | 1995-02-02 | 1996-04-02 | Reitano Joseph R | Inhaler case |
| US5901703A (en) | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
| US5660835A (en) | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
| JPH11501892A (ja) | 1995-03-10 | 1999-02-16 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | エアロゾルバルブ |
| US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
| US5542539A (en) | 1995-04-04 | 1996-08-06 | Ethicon Endo-Surgery, Inc. | Container for quick release packages for surgical instruments |
| USD377215S (en) | 1995-04-13 | 1997-01-07 | Glaxo Group Limited | Inhaler |
| US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
| US5990077A (en) | 1995-04-14 | 1999-11-23 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
| US5622166A (en) | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
| US5921237A (en) | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
| US5809997A (en) | 1995-05-18 | 1998-09-22 | Medtrac Technologies, Inc. | Electronic medication chronolog device |
| US5924419A (en) | 1995-05-22 | 1999-07-20 | Kotliar; Igor K. | Apparatus for passive hypoxic training and therapy |
| DE19519840A1 (de) | 1995-05-31 | 1996-12-05 | Kaewert Klaus | Gelantinekapsel |
| AU128811S (en) | 1995-06-06 | 1996-12-03 | Orion Yhtymae Oy | A protective cover for example a moisture protective cover for a powder inhaler |
| US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
| US5641861A (en) | 1995-06-07 | 1997-06-24 | Torrey Pines Institute For Molecular Studies | μopioid receptor ligands: agonists and antagonists |
| US6193844B1 (en) | 1995-06-07 | 2001-02-27 | Mclaughlin John R. | Method for making paper using microparticles |
| US5919897A (en) | 1995-06-07 | 1999-07-06 | Torrey Pines Institute For Molecular Studies | MU opioid receptor ligands: agonists and antagonists |
| US5824345A (en) | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
| US5610271A (en) | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
| US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
| US6357442B1 (en) | 1995-06-08 | 2002-03-19 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIS) |
| PL182198B1 (en) | 1995-06-21 | 2001-11-30 | Asta Medica Ag | Pharmaceutic powder holding container with integrated measuring device and powdered |
| GB9513218D0 (en) | 1995-06-29 | 1995-09-06 | Fisons Plc | Inhalation device and method |
| DE19523516C1 (de) | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
| USD379506S (en) | 1995-07-01 | 1997-05-27 | Glaxo Group Limited | Inhaler |
| JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| US5758638A (en) | 1995-07-24 | 1998-06-02 | Kreamer; Jeffry W. | Indicator for a medicament inhaler |
| US5642727A (en) | 1995-07-25 | 1997-07-01 | David Sarnoff Research Center, Inc. | Inhaler apparatus using a tribo-electric charging technique |
| WO1997004747A1 (en) | 1995-07-27 | 1997-02-13 | Dunn James M | Drug delivery systems for macromolecular drugs |
| US6209538B1 (en) | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
| SE9502799D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Device in inhalers |
| SE9502800D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Disposable inhaler |
| JP3317823B2 (ja) | 1995-08-11 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
| US5746197A (en) | 1995-08-18 | 1998-05-05 | Williams; Jeffery W. | Extension for metered dose inhaler |
| US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
| US5690910A (en) | 1995-08-18 | 1997-11-25 | Baker Norton Pharmaceuticals, Inc. | Method for treating asthma |
| US6852690B1 (en) | 1995-08-22 | 2005-02-08 | Amylin Pharmaceuticals, Inc. | Method and composition for enhanced parenteral nutrition |
| FR2738153B1 (fr) | 1995-09-04 | 1998-01-02 | Valois | Appareil d'inhalation destine a distribuer des doses precises et reproductibles de produit pulverulent |
| US5617844A (en) | 1995-09-21 | 1997-04-08 | King; Russell W. | Aerosol medication delivery system |
| KR0124764Y1 (ko) | 1995-09-23 | 1998-09-15 | 양주환 | 의약 및 식품용 하드 공 캅셀 |
| SE9503344D0 (sv) | 1995-09-27 | 1995-09-27 | Astra Ab | Inhalation device |
| US5849322A (en) | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
| US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
| EP0861089B1 (en) | 1995-11-13 | 2002-07-17 | Medtronic MiniMed, Inc. | Methods and compositions for the delivery of monomeric proteins |
| DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
| US6182655B1 (en) | 1995-12-07 | 2001-02-06 | Jago Research Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| CN1213974A (zh) | 1996-01-03 | 1999-04-14 | 葛兰素集团有限公司 | 吸入器具 |
| US6026809A (en) | 1996-01-25 | 2000-02-22 | Microdose Technologies, Inc. | Inhalation device |
| US6470884B2 (en) | 1996-01-29 | 2002-10-29 | Aventis Pharma Limited | Capsule opening arrangement for use in a powder inhaler |
| JPH09208485A (ja) | 1996-01-31 | 1997-08-12 | Teijin Ltd | ペプチド・蛋白質性薬物の水難溶性組成物 |
| US6156114A (en) | 1996-02-06 | 2000-12-05 | E. I. Du Pont De Nemours And Company | Treatment of deagglomerated particles with plasma-activated species |
| USD381416S (en) | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
| DK0883415T3 (da) | 1996-02-21 | 2002-08-19 | Schering Corp | Inhalator til pulverformigt medikament |
| USD377861S (en) | 1996-02-21 | 1997-02-11 | Medport, Inc. | Inhaler carrying case |
| CN1155368C (zh) | 1996-02-27 | 2004-06-30 | 帝人株式会社 | 鼻腔给药的粉剂组合物 |
| US6509313B1 (en) | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
| US5699789A (en) | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
| JP3328132B2 (ja) | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | 吸入式投薬器 |
| GB9606188D0 (en) | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
| USD395499S (en) | 1996-04-08 | 1998-06-23 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US5858099A (en) | 1996-04-09 | 1999-01-12 | Sarnoff Corporation | Electrostatic chucks and a particle deposition apparatus therefor |
| US5875776A (en) | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
| DE69724420T2 (de) | 1996-04-29 | 2004-06-09 | Quadrant Technologies Ltd. | Verfahren zum inhalieren trockener pulver |
| US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
| AU132977S (en) | 1996-05-17 | 1998-02-17 | Astrazeneca Ab | Container for inhaling apparatus |
| USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| JP2000512280A (ja) | 1996-06-05 | 2000-09-19 | ラポポート,バジル | ヒト甲状腺刺激ホルモンレセプター組成物およびその使用 |
| US5871010A (en) | 1996-06-10 | 1999-02-16 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
| AUPO066096A0 (en) | 1996-06-26 | 1996-07-18 | Peptide Delivery Systems Pty Ltd | Oral delivery of peptides |
| US5769276A (en) | 1996-07-10 | 1998-06-23 | Terronics Development Corporation | Powder atomizer |
| US5783556A (en) | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
| AU133903S (en) | 1996-08-19 | 1998-05-29 | Orion Yhtymae Oy | Inhaler device |
| US6277819B1 (en) | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
| JP3890099B2 (ja) | 1996-09-30 | 2007-03-07 | キヤノン株式会社 | パターン認識装置及びその方法、及びそのプログラムを記憶した記憶媒体 |
| JP3020141B2 (ja) | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
| US6532437B1 (en) | 1996-10-23 | 2003-03-11 | Cornell Research Foundation, Inc. | Crystalline frap complex |
| UA65549C2 (uk) | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
| US6441172B1 (en) | 1996-11-07 | 2002-08-27 | Torrey Pines Institute For Molecular Studies | Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| EP0941114B1 (en) | 1996-11-12 | 2005-02-23 | Novo Nordisk A/S | Use of glp-1 peptides |
| DE19647947A1 (de) | 1996-11-20 | 1998-05-28 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| US5868774A (en) | 1996-11-21 | 1999-02-09 | Reil; Vladimir | Unique cartridge and earring stud gun system |
| US6159360A (en) | 1996-11-22 | 2000-12-12 | Heinkel Industriezentrifugen Gmbh & Co. | Invertible filter centrifuge including a solids drier |
| AU7845698A (en) | 1996-12-11 | 1998-07-03 | John Hugo Nellmapius | Methods and apparatus for use in processing and treating particulate materia |
| USD390651S (en) | 1996-12-12 | 1998-02-10 | Inhale Therapeutics Systems | Medicament inhaler housing |
| GB9626263D0 (en) | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
| GB9626233D0 (en) | 1996-12-18 | 1997-02-05 | Chawla Brinda P S | Medicament packaging and deliveery device |
| GB2320489A (en) | 1996-12-20 | 1998-06-24 | Norton Healthcare Ltd | Inhaler dose counter |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
| USD397435S (en) | 1997-01-03 | 1998-08-25 | GGU Gesellschaft fuer Gesundheits-und Umweltforschung mbH | Combined inhaler and cover |
| US5794613A (en) | 1997-01-09 | 1998-08-18 | Sepracor, Inc. | Multiple-dose dispenser for dry powder inhalers |
| USD389238S (en) | 1997-01-24 | 1998-01-13 | Healthscan Products, Inc. | Inhaler mask |
| US6884435B1 (en) | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| EP0898978B1 (en) | 1997-01-30 | 2005-03-02 | Unisia Jecs Corporation | Suction type medicator |
| SE9700422D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler II |
| SE9700424D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Powder inhaler |
| SE9700421D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler I |
| SE9700423D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Disposable inhaler |
| JP3011898B2 (ja) | 1997-02-20 | 2000-02-21 | フォルテ グロウ メディカル株式会社 | 吸引器 |
| DE19708406A1 (de) | 1997-03-03 | 1998-09-10 | Alfred Von Schuckmann | Gerät zur dosierten Ausgabe von Substanzen |
| USD390653S (en) | 1997-03-04 | 1998-02-10 | Blasdell Richard J | Inhaler |
| SE9700940D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler IV |
| SE9700937D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler I |
| TW469832U (en) | 1997-03-14 | 2001-12-21 | Astra Ab | Inhalation device |
| SE9700948D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler X |
| SE9700938D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler II and a method of construction thereof |
| SE9700935D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
| SE9700936D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
| SE9700943D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler V |
| US6006747A (en) | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| US6043214A (en) | 1997-03-20 | 2000-03-28 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
| US5904139A (en) | 1997-03-28 | 1999-05-18 | Hauser; Stephen G. | Breath coordinated inhaler |
| US5981488A (en) | 1997-03-31 | 1999-11-09 | Eli Lillly And Company | Glucagon-like peptide-1 analogs |
| WO1998043893A1 (en) | 1997-04-01 | 1998-10-08 | Cima Labs Inc. | Blister package and packaged tablet |
| EP0975328A1 (en) | 1997-04-02 | 2000-02-02 | Purdue Research Foundation | Method for oral delivery of proteins |
| PT101988B (pt) | 1997-04-04 | 2004-02-27 | Hovione Farmaciencia Sa | Sistema de orientacao e posicionamento de um objecto |
| USD410541S (en) | 1997-06-30 | 1999-06-01 | Novartis Ag | Inhaler |
| SE9702796D0 (sv) | 1997-07-25 | 1997-07-25 | Pharmacia & Upjohn Ab | A device at a pharmaceutical container or inhaler |
| CA2212430A1 (en) | 1997-08-07 | 1999-02-07 | George Volgyesi | Inhalation device |
| GB2327895B (en) | 1997-08-08 | 2001-08-08 | Electrosols Ltd | A dispensing device |
| US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
| US5846447A (en) | 1997-08-26 | 1998-12-08 | E. I. Du Pont De Nemours And Company | Process for forming a dispersion of polytetrafluoroethylene |
| USD416621S (en) | 1997-09-05 | 1999-11-16 | Pharmacia & Upjohn | Two piece inhaler |
| USD417271S (en) | 1997-09-10 | 1999-11-30 | Medic-Aid Limited | Drug delivery device |
| WO1999014239A1 (de) | 1997-09-12 | 1999-03-25 | Wolf Georg Forssmann | Zusammensetzung zur therapie von diabetes mellitus und fettsucht |
| US5848589A (en) | 1997-09-18 | 1998-12-15 | Welnetz; Robert J. | Altitude mask simulator |
| AU135340S (en) | 1997-09-24 | 1998-10-12 | Innovata Biomed Ltd | An inhaler |
| US6394085B1 (en) | 1997-09-25 | 2002-05-28 | Norton Healthcare Ltd. | Inhaler spacer |
| US6073629A (en) | 1997-09-25 | 2000-06-13 | Norton Healthcare Ltd. | Inhaler spacer |
| USD463544S1 (en) | 1997-09-26 | 2002-09-24 | 1263152 Ontario Inc. | Aerosol medication delivery inhaler |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| WO1999016417A1 (en) | 1997-10-01 | 1999-04-08 | Flemington Pharmaceutical Corporation | Buccal, polar and non-polar spray or capsule |
| US6228394B1 (en) | 1997-10-14 | 2001-05-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Supercritical fluid extraction of mould lubricant from hard shell capsules |
| US5954047A (en) | 1997-10-17 | 1999-09-21 | Systemic Pulmonary Development, Ltd. | Methods and apparatus for delivering aerosolized medication |
| USD398992S (en) | 1997-10-21 | 1998-09-29 | Schering-Plough Healthcare Products, Inc. | Nasal inhaler |
| ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
| IN188720B (pt) | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
| AU135120S (en) | 1997-11-14 | 1998-09-21 | Astrazeneca Ab | Inhaler |
| SE9704184D0 (sv) | 1997-11-14 | 1997-11-14 | Astra Ab | Inhalation device |
| USD412978S (en) | 1997-12-02 | 1999-08-17 | Dura Pharmaceuticals, Inc. | Inhaler |
| US6116238A (en) | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
| USD418600S (en) | 1997-12-04 | 2000-01-04 | Charmaine Haerle | Inhaler clip |
| AU1617399A (en) | 1997-12-05 | 1999-06-28 | Eli Lilly And Company | Glp-1 formulations |
| US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
| US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
| US5965701A (en) | 1997-12-23 | 1999-10-12 | Ferring Bv | Kappa receptor opioid peptides |
| US6077940A (en) | 1997-12-24 | 2000-06-20 | Genentech, Inc. | Free solution ligand interaction molecular separation method |
| US6358058B1 (en) | 1998-01-30 | 2002-03-19 | 1263152 Ontario Inc. | Aerosol dispensing inhaler training device |
| JP3530004B2 (ja) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| US6158431A (en) | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
| USD421800S (en) | 1998-02-19 | 2000-03-21 | Pierre Fabre Medicament | Powder and compressed-air inhaler |
| USD412979S (en) | 1998-02-27 | 1999-08-17 | Diemolding Corporation | Metered dose inhaler spacer |
| US7143764B1 (en) | 1998-03-13 | 2006-12-05 | Astrazeneca Ab | Inhalation device |
| GEP20043260B (en) | 1998-03-16 | 2004-06-25 | Nectar Therapeutics | Aerosolized Active Agent Delivery and Device for Realization Thereof |
| US6998387B1 (en) | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
| SE9801078D0 (sv) | 1998-03-27 | 1998-03-27 | Shl Medical Ab | Inhalator |
| AU138847S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
| AU138849S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
| AU138848S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
| EP1067839A1 (en) | 1998-04-08 | 2001-01-17 | Eli Lilly And Company | Pulmonary and nasal delivery of raloxifene |
| PL343342A1 (en) | 1998-04-09 | 2001-08-13 | Axiva Gmbh | Particulate active agent support for pulmonary application |
| FR2777283B1 (fr) | 1998-04-10 | 2000-11-24 | Adir | Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6578571B1 (en) | 1998-04-20 | 2003-06-17 | Infamed Ltd. | Drug delivery device and methods therefor |
| GB9810126D0 (pt) | 1998-05-13 | 1998-07-08 | Glaxo Group Ltd | |
| US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
| SE9802080D0 (sv) | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| JP2002517469A (ja) | 1998-06-12 | 2002-06-18 | バイオネブラスカ,インコーポレイテッド | グルカゴン様ペプチド−1は、耐糖能異常を有する対象におけるグルコースに対するβ細胞応答を改善する |
| US6152130A (en) | 1998-06-12 | 2000-11-28 | Microdose Technologies, Inc. | Inhalation device with acoustic control |
| USD412572S (en) | 1998-06-19 | 1999-08-03 | Gray Gene W | Nasal inhaler adaptor for left and right nostril |
| IL140312A0 (en) | 1998-06-22 | 2002-02-10 | Astrazeneca Ab | Device for emptying cavities containing powder by means of suction |
| JP2002519366A (ja) | 1998-07-07 | 2002-07-02 | トランスダーマル・テクノロジーズ・インコーポレーテツド | 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達 |
| DE19831525A1 (de) | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
| AU762145C (en) | 1998-08-26 | 2005-03-17 | Teijin Limited | Powdery pernasal compositions |
| CO5090908A1 (es) | 1998-08-28 | 2001-10-30 | Lilly Co Eli | Procedimiento para administrar peptidos insulinotropicos |
| US6720407B1 (en) | 1998-08-28 | 2004-04-13 | Eli Lilly And Company | Method for administering insulinotropic peptides |
| WO2000016836A1 (en) | 1998-09-24 | 2000-03-30 | Astrazeneca Ab | Inhaler |
| US20020088458A1 (en) | 1998-09-24 | 2002-07-11 | Astrazeneca Ab | Inhaler |
| GB9820886D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
| GB9820937D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
| US6187291B1 (en) | 1998-09-28 | 2001-02-13 | Robert Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
| USD411005S (en) | 1998-09-29 | 1999-06-15 | Pharmadesign Inc. | Arthritic aid for metered dose inhaler |
| UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
| US6279511B1 (en) | 1998-10-23 | 2001-08-28 | Instech Laboratories, Inc. | Powered multichannel infusion and monitoring system |
| US6263871B1 (en) | 1998-10-29 | 2001-07-24 | Richard I. Brown | Mouthpiece with coupler |
| US6235725B1 (en) | 1998-10-30 | 2001-05-22 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for the prevention of tolerance to medications |
| US6261594B1 (en) | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
| US6540672B1 (en) | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
| GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
| US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| SE9900215D0 (sv) | 1999-01-26 | 1999-01-26 | Pharmacia & Upjohn Ab | New use |
| JP2000217917A (ja) | 1999-01-27 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
| PT1158958E (pt) | 1999-03-05 | 2007-08-13 | Chiesi Farma Spa | ''composições farmacêuticas em pó, melhoradas, para inalação'' |
| US6632258B1 (en) | 1999-03-16 | 2003-10-14 | The United States Of America As Represented By The United States Department Of Energy | Coal beneficiation by gas agglomeration |
| US6803044B1 (en) | 1999-03-24 | 2004-10-12 | Zengen, Inc. | Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus |
| US6630169B1 (en) | 1999-03-31 | 2003-10-07 | Nektar Therapeutics | Particulate delivery systems and methods of use |
| DK1165050T3 (da) | 1999-04-05 | 2006-05-01 | Mannkind Corp | Fremgangsmåde til dannelse af fint pulver |
| USD441859S1 (en) | 1999-04-06 | 2001-05-08 | Istituto Biochimico Pavese Pharma S.P.A. | Disposable dry-powder inhaler |
| BR0010346A (pt) | 1999-05-07 | 2002-02-19 | Imerys Pigments Inc | Método de tratamento de um material particulado de caulim |
| US6417920B1 (en) | 1999-05-11 | 2002-07-09 | Shimadzu Corporation | Particle size analyzer based on laser diffraction method |
| US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
| GB9911388D0 (en) | 1999-05-18 | 1999-07-14 | Glaxo Group Ltd | Dispenser |
| KR20020012221A (ko) | 1999-05-20 | 2002-02-15 | 파르마솔 게엠베하 | 체액성 및 세포성 면역 반응을 증진시키기 위한, 안정성과생체 적합성이 최적화된 애쥬반트 |
| US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| EP1060741B1 (en) | 1999-06-14 | 2003-09-03 | Baxter International Inc. | Sustained release microspheres |
| US6644315B2 (en) | 1999-06-18 | 2003-11-11 | Saeed Ziaee | Nasal mask |
| SE516826C2 (sv) | 1999-06-18 | 2002-03-05 | Shl Medical Ab | Anordning i en inhalator med organ för aktivering och avaktivering av en kanister som svar på ett luftflöde |
| US7169889B1 (en) | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
| SI1133312T1 (sl) | 1999-06-21 | 2008-02-29 | Lilly Co Eli | Uporaba tiazolidindionov v kombinaciji z glukagonu podobnim peptidom-1 in njegovimi agonisti za zdravljenje sladkorne bolezni, neodvisne od inzulina |
| US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| GB2353222B (en) | 1999-06-23 | 2001-09-19 | Cambridge Consultants | Inhalers |
| USD444226S1 (en) | 1999-06-24 | 2001-06-26 | Novo Nordisk A/S | Inhaler |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| ES2395096T3 (es) | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas |
| US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
| ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
| IL147756A (en) | 1999-07-22 | 2005-12-18 | Aventis Pharma Inc | Preserved pharmaceutical formulations |
| US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
| US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
| ATE390944T1 (de) | 1999-07-23 | 2008-04-15 | Mannkind Corp | Einzelportionskapseln für einen trockenpulverinhalator |
| CN1175961C (zh) | 1999-09-17 | 2004-11-17 | 株式会社新王磁材 | 稀土合金的切割方法和切割装置 |
| USD438612S1 (en) | 1999-09-27 | 2001-03-06 | G-Intek Co., Ltd. | Snivel inhaler |
| JP2003511107A (ja) | 1999-10-06 | 2003-03-25 | ゴルデマン・ラウル | 乾燥粉末の呼吸制御式吸入器と、乾燥粉末を空気に均一に分配混合する方法 |
| DE60025019T2 (de) | 1999-10-29 | 2006-08-24 | Nektar Therapeutics, San Carlos | Trockenpulverzusammensetzungen mit verbesserter dispersivität |
| SE9903990D0 (sv) | 1999-11-02 | 1999-11-02 | Shl Medical Ab | Inhalator with aerosolizing unit |
| GB9928311D0 (en) | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
| IT1308581B1 (it) | 1999-12-03 | 2002-01-08 | Medel Italiana Srl | Apparato per nebulizzare un liquido, in particolare per uso medico. |
| SE9904706D0 (sv) | 1999-12-21 | 1999-12-21 | Astra Ab | An inhalation device |
| PE20010720A1 (es) | 1999-12-11 | 2001-07-26 | Glaxo Group Ltd | Distribuidor de medicamento |
| US7204250B1 (en) | 1999-12-16 | 2007-04-17 | Compumedics Limited | Bio-mask |
| US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
| DE19961300A1 (de) | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
| EP1242112A4 (en) | 1999-12-21 | 2005-02-09 | Rxkinetix Inc | PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME |
| US7080642B2 (en) | 1999-12-22 | 2006-07-25 | 3M Innovative Properties Company | Refillable device with counting means |
| WO2001049274A2 (en) | 1999-12-30 | 2001-07-12 | Chiron Corporation | Methods for pulmonary delivery of interleukin-2 |
| US6894026B1 (en) | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
| AU2353701A (en) | 2000-01-11 | 2001-07-24 | Novo Nordisk A/S | Transepithelial delivery of glp-1 derivatives |
| US7833549B2 (en) | 2000-01-19 | 2010-11-16 | Mannkind Corporation | Dry powder formulations of antihistamine for nasal administration |
| WO2001052813A1 (en) | 2000-01-19 | 2001-07-26 | Pharmaceutical Discovery Corporation | Multi-spike release formulation for drug delivery |
| US6540983B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
| US6540982B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
| ATE264870T1 (de) | 2000-01-27 | 2004-05-15 | Lilly Co Eli | Verfahren zur lösung von glucagon-ähnlichen peptid-1 (glp-1) verbindungen |
| US6427688B1 (en) | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
| US7171965B2 (en) | 2000-02-01 | 2007-02-06 | Valois S.A.S. | Breath actuated dry powder inhaler and tape dose strip |
| USD439325S1 (en) | 2000-02-08 | 2001-03-20 | Baker Norton Pharmaceuticals, Inc. | Cover for a nasal inhaler |
| EP1129705A1 (en) | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
| GB0004456D0 (en) | 2000-02-26 | 2000-04-19 | Glaxo Group Ltd | Medicament dispenser |
| PL204106B1 (pl) | 2000-02-28 | 2009-12-31 | Pharmakodex Ltd | Zestaw do dostarczania środka terapeutycznego |
| USD439656S1 (en) | 2000-03-06 | 2001-03-27 | Astrazeneca Uk Limited | Inhaler |
| US6443151B1 (en) | 2000-03-08 | 2002-09-03 | Aradigm Corporation | Fluid velocity-sensitive trigger mechanism |
| WO2001068169A1 (en) | 2000-03-10 | 2001-09-20 | University Of North Carolina At Chapel Hill | Dry powder inhaler devices, multi-dose dry powder drug packages, control systems, and associated methods |
| US6608038B2 (en) | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
| GB2360216A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
| GB2360218A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
| US6823863B2 (en) | 2000-03-18 | 2004-11-30 | Astrazeneca Ab | Inhaler |
| GB0006525D0 (en) | 2000-03-18 | 2000-05-10 | Astrazeneca Uk Ltd | Inhaler |
| SE0000935D0 (sv) | 2000-03-21 | 2000-03-21 | Astrazeneca Ab | An inhalation device |
| AU145610S (en) | 2000-03-24 | 2001-10-18 | Astrazeneca U K Ltd | Inhaler |
| US6432383B1 (en) | 2000-03-30 | 2002-08-13 | Generex Pharmaceuticals Incorporated | Method for administering insulin |
| WO2001074247A2 (en) | 2000-04-03 | 2001-10-11 | Iep Pharmaceutical Devices Inc. | Method for measuring changes in the airways of humans and other mammals |
| US6998137B2 (en) | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| CA2826724C (en) | 2000-04-11 | 2016-02-02 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
| DE10019879A1 (de) * | 2000-04-20 | 2001-10-25 | Degussa | Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung |
| MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
| US6447750B1 (en) | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
| US6468507B1 (en) | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
| USD442685S1 (en) | 2000-05-02 | 2001-05-22 | Salter Labs | Medication inhaler spacer |
| US20010039442A1 (en) | 2000-05-06 | 2001-11-08 | Sal Gorge | Headache relief device |
| US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
| US20020000225A1 (en) | 2000-06-02 | 2002-01-03 | Carlos Schuler | Lockout mechanism for aerosol drug delivery devices |
| CN1141974C (zh) | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
| DE60137876D1 (de) | 2000-06-16 | 2009-04-16 | Lilly Co Eli | Analoge des Glucagon-ähnlichen Peptids-1 |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| GB0015034D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Inhalation device |
| GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
| PE20020067A1 (es) | 2000-06-23 | 2002-02-05 | Norton Healthcare Ltd | Desaglomerador para inhalador de polvo seco accionado por la respiracion |
| US6562807B2 (en) | 2000-06-23 | 2003-05-13 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| PE20020066A1 (es) | 2000-06-23 | 2002-02-23 | Norton Healthcare Ltd | Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion |
| TWI224513B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Dose counter for medicament inhaler |
| USD450117S1 (en) | 2000-06-29 | 2001-11-06 | Innovata Biomed Limited | Inhaler |
| USD452910S1 (en) | 2000-06-29 | 2002-01-08 | Innovata Biomend Limited | Inhaler |
| MXPA02012272A (es) | 2000-07-04 | 2003-04-25 | Novo Nordisk As | Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv. |
| US6363932B1 (en) | 2000-07-06 | 2002-04-02 | Clinical Technologies, Inc. | Aerosol enhancement device |
| US6951215B1 (en) | 2000-07-14 | 2005-10-04 | Tufts University | Drug delivery device for animals |
| US6360929B1 (en) | 2000-07-17 | 2002-03-26 | Mccarthy Madeleine | Medicinal atomizing inhaler pouch/retainer |
| GB2364919A (en) | 2000-07-21 | 2002-02-13 | Cambridge Consultants | Inhalers |
| US6967202B2 (en) | 2000-08-04 | 2005-11-22 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
| SE0002822L (sv) | 2000-08-04 | 2002-01-29 | Microdrug Ag | Elektropulver |
| JP5048201B2 (ja) | 2000-08-04 | 2012-10-17 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物 |
| CA2417826A1 (en) | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| MXPA03001092A (es) | 2000-08-07 | 2003-09-25 | Nektar Therapeutics Al Corp | Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada. |
| WO2002013897A2 (en) | 2000-08-14 | 2002-02-21 | Advanced Inhalation Research, Inc. | Inhalation device and method |
| US6704255B2 (en) | 2000-08-22 | 2004-03-09 | Ricoh Company, Ltd. | Lens actuator |
| US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| USD460173S1 (en) | 2000-09-20 | 2002-07-09 | P.A. Knowledge Limited | Inhaler device |
| EP1409051A2 (de) | 2000-09-20 | 2004-04-21 | Franco Del Bon | Inhalationsvorrichtung und zugehörige zerstäubungsvorrichtung |
| SE517225C2 (sv) | 2000-09-21 | 2002-05-14 | Microdrug Ag | Optimering av en elektrostatiskt doserad inhalator för torrt pulver |
| SE517226C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator med luftbroms för torrt pulver |
| SE517228C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator för torrt pulver med andningsaktivering |
| GB0023653D0 (en) | 2000-09-27 | 2000-11-08 | Cambridge Consultants | Device for dispensing particulate material |
| ES2336544T3 (es) | 2000-09-29 | 2010-04-14 | Pfizer Limited | Dispositivo medico de inhalacion. |
| US6756062B2 (en) | 2000-11-03 | 2004-06-29 | Board Of Regents University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
| CN100400031C (zh) | 2000-11-29 | 2008-07-09 | 伊藤火腿株式会社 | 粉末制剂及其制备方法 |
| GB0029562D0 (en) | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
| USD455208S1 (en) | 2000-12-05 | 2002-04-02 | Clinical Designs Limited | Inhaler |
| AU2002239384B2 (en) | 2000-12-13 | 2007-01-11 | Eli Lilly And Company | Chronic treatment regimen using glucagon-like insulinotropic peptides |
| WO2002055101A2 (en) | 2000-12-21 | 2002-07-18 | Inhale Therapeutic Syst | Storage stable powder compositions of interleukin-4 receptor |
| US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
| US7077130B2 (en) | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
| US20020141946A1 (en) | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
| CA2433335C (en) | 2000-12-29 | 2010-04-20 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
| US6626173B2 (en) | 2001-01-08 | 2003-09-30 | Iep Pharmaceutical Devices Inc. | Dry powder inhaler |
| US6644309B2 (en) | 2001-01-12 | 2003-11-11 | Becton, Dickinson And Company | Medicament respiratory delivery device and method |
| FI20010144A0 (fi) | 2001-01-24 | 2001-01-24 | Valtion Teknillinen | Menetelmä ja laite aerosolilähteiden tutkimiseksi |
| AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
| US20040022861A1 (en) | 2001-01-30 | 2004-02-05 | Williams Robert O. | Process for production of nanoparticles and microparticles by spray freezing into liquid |
| WO2002067995A1 (en) | 2001-02-26 | 2002-09-06 | Council Of Scientific And Industrial Research | Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
| EP1238680B1 (en) | 2001-03-05 | 2003-12-10 | Ivo Pera | Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract |
| US6523536B2 (en) | 2001-03-12 | 2003-02-25 | Birdsong Medical Devices, Inc. | Dual-canister inhaler having a spacer and easy to operate lever mechanism |
| US6698422B2 (en) | 2001-03-12 | 2004-03-02 | Birdsong Medical Devices, Inc. | Canister inhaler having a spacer and easy to operate lever mechanism and a flexible, elastic mouthpiece |
| USD453264S1 (en) | 2001-03-30 | 2002-02-05 | Benjamin Acevedo, Jr. | Pouch for medical inhaler |
| GB0108213D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
| US6652838B2 (en) | 2001-04-05 | 2003-11-25 | Robert E. Weinstein | Method for treating diabetes mellitus |
| SE518397C2 (sv) | 2001-04-05 | 2002-10-01 | Microdrug Ag | Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver |
| DK1385856T3 (da) | 2001-04-11 | 2006-05-15 | Bristol Myers Squibb Co | Aminosyrekomplekser af C-aryl-glucosider til behandling af diabetes og fremgangsmåder |
| US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US6447751B1 (en) | 2001-04-18 | 2002-09-10 | Robert E. Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
| CA2504976C (en) | 2001-04-19 | 2011-10-11 | Technology Innovation Limited | Medicament container |
| USD451597S1 (en) | 2001-04-24 | 2001-12-04 | G-Intek Co.,Ltd | Snivel inhaler |
| US7232897B2 (en) | 2001-04-24 | 2007-06-19 | Harvard University, President And Fellows Of Harvard College | Compositions and methods for modulating NH2-terminal Jun Kinase activity |
| JP4663906B2 (ja) | 2001-04-26 | 2011-04-06 | 富士フイルム株式会社 | セルロースアシレートフイルム |
| KR20040023597A (ko) | 2001-05-10 | 2004-03-18 | 벡투라 딜리버리 디바이시스 리미티드 | 흡입기들 |
| GB2375308A (en) | 2001-05-10 | 2002-11-13 | Cambridge Consultants | Inhalers |
| KR20030097876A (ko) | 2001-05-21 | 2003-12-31 | 넥타르 테라퓨틱스 | 화학적으로 개질된 인슐린의 폐 투여 |
| SE0101825D0 (sv) | 2001-05-22 | 2001-05-22 | Astrazeneca Ab | An Inhalation device |
| JP2005506956A (ja) | 2001-06-01 | 2005-03-10 | イーライ・リリー・アンド・カンパニー | 長時間作用性glp−1製剤 |
| US7035294B2 (en) | 2001-06-04 | 2006-04-25 | Calix Networks, Inc. | Backplane bus |
| EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| FI20011317A0 (fi) | 2001-06-20 | 2001-06-20 | Orion Corp | Jauheinhalaattori |
| DE60205487T2 (de) | 2001-06-22 | 2006-06-01 | 3M Innovative Properties Co., St. Paul | Verfahren zur verbesserung des durchflusses einer aerosolformulierung in einem dosierventil für einen dosierinhalator |
| US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
| DE10136555A1 (de) | 2001-07-27 | 2003-02-13 | Boehringer Ingelheim Int | Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren |
| US7414720B2 (en) | 2001-07-27 | 2008-08-19 | Herbert Wachtel | Measuring particle size distribution in pharmaceutical aerosols |
| GB0120018D0 (en) | 2001-08-16 | 2001-10-10 | Meridica Ltd | Pack containing medicament and dispensing device |
| JP2005505538A (ja) | 2001-08-22 | 2005-02-24 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | アリール置換プロパノールアミン誘導体と他の活性成分との組み合わせ物およびその使用 |
| AU2002322403A1 (en) | 2001-08-23 | 2003-03-10 | Eli Lilly And Company | Glucagon-like peptide-1 analogs |
| WO2003020201A2 (en) | 2001-08-28 | 2003-03-13 | Eli Lilly And Company | Pre-mixes of glp-1 and basal insulin |
| GB0121709D0 (en) | 2001-09-07 | 2001-10-31 | Imp College Innovations Ltd | Food inhibition agent |
| EP1487417A4 (en) | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS |
| US6871647B2 (en) | 2001-09-19 | 2005-03-29 | Advent Pharmaceuticals Pty Ltd | Inhaler |
| US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
| US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
| AU2002340083A1 (en) | 2001-09-28 | 2003-04-07 | Kurve Technology, Inc | Nasal nebulizer |
| US7093595B2 (en) | 2001-10-08 | 2006-08-22 | Eli Lilly And Company | Portable medication inhalation kit |
| EP1436439B1 (en) | 2001-10-16 | 2008-07-02 | International Non-Toxic Composites Corp. | High density non-toxic composites comprising tungsten, another metal and polymer powder |
| USD461239S1 (en) | 2001-10-18 | 2002-08-06 | Anna L. Cassidy | Inhaler sleeve with spring clip |
| EP1448222A4 (en) | 2001-10-19 | 2006-05-17 | Lilly Co Eli | BIPHASIC MIXTURES OF GLP-1 AND INSULIN |
| JP2005508220A (ja) | 2001-10-24 | 2005-03-31 | パーリ・ゲーエムベーハー | 薬用組成物調製用具 |
| USD473298S1 (en) | 2001-11-01 | 2003-04-15 | Astrazeneca Ab | Inhaler refill |
| MXPA04005382A (es) | 2001-11-07 | 2005-02-24 | Mannkind Corp | Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno. |
| TWI324518B (en) | 2001-12-19 | 2010-05-11 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| US6994083B2 (en) | 2001-12-21 | 2006-02-07 | Trudell Medical International | Nebulizer apparatus and method |
| GB0130857D0 (en) | 2001-12-22 | 2002-02-06 | Glaxo Group Ltd | Medicament dispenser |
| USD471273S1 (en) | 2002-01-07 | 2003-03-04 | Aerogen, Inc. | Inhaler for dispensing medication |
| USD479745S1 (en) | 2002-01-07 | 2003-09-16 | Aerogen, Inc. | Inhaler for dispensing medications |
| USD469866S1 (en) | 2002-01-07 | 2003-02-04 | Aerogen, Inc. | Inhaler for dispensing medication |
| US20030198666A1 (en) | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
| USD474536S1 (en) | 2002-01-07 | 2003-05-13 | Aerogen, Inc. | Inhaler for dispensing medications |
| ITMI20020078A1 (it) | 2002-01-16 | 2003-07-16 | Fabrizio Niccolai | Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie |
| US6991779B2 (en) | 2002-01-18 | 2006-01-31 | Mannkind Corporation | Compositions for treatment or prevention of bioterrorism |
| US7105489B2 (en) | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
| US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| AU2003208945B2 (en) | 2002-02-20 | 2008-05-01 | Emisphere Technologies, Inc | Method for administering GLP-1 molecules |
| US6591832B1 (en) | 2002-02-21 | 2003-07-15 | Saint-Gobain Calmar Inc. | Dry powder dispenser |
| US6830149B2 (en) | 2002-03-08 | 2004-12-14 | Musculoskeletal Transplant Foundation | Package with insert for holding allograft implant to preclude lipid transfer |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
| UA80123C2 (en) | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
| US20030235538A1 (en) | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
| US20030194420A1 (en) | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
| USD475133S1 (en) | 2002-04-18 | 2003-05-27 | Mcluckie Lynne E. | Luminescent-colored inhaler |
| US7316748B2 (en) | 2002-04-24 | 2008-01-08 | Wisconsin Alumni Research Foundation | Apparatus and method of dispensing small-scale powders |
| US6830046B2 (en) | 2002-04-29 | 2004-12-14 | Hewlett-Packard Development Company, L.P. | Metered dose inhaler |
| USD478983S1 (en) | 2002-05-01 | 2003-08-26 | Chrysalis Technologies Incorporated | Inhaler |
| US20040151059A1 (en) | 2002-05-01 | 2004-08-05 | Roberts Ii William Leroy | Deagglomerator apparatus and method |
| AU2003218635A1 (en) | 2002-05-07 | 2003-11-11 | Novo Nordisk A/S | Soluble formulations comprising insulin aspart and insulin detemir |
| US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
| USD473640S1 (en) | 2002-05-13 | 2003-04-22 | Iep Pharmaceutical Devices Inc. | Breath actuated inhaler |
| USD492769S1 (en) | 2002-05-24 | 2004-07-06 | Glaxosmithkline K.K. | Lens for an inhaler |
| USD477665S1 (en) | 2002-06-12 | 2003-07-22 | Microdrug Ag | Inhaler |
| AU154760S (en) | 2002-06-20 | 2004-03-02 | Astrazeneca Ab | Inhaler |
| US8003179B2 (en) | 2002-06-20 | 2011-08-23 | Alcan Packaging Flexible France | Films having a desiccant material incorporated therein and methods of use and manufacture |
| EP1531794B1 (en) | 2002-06-28 | 2017-05-10 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
| US20060003316A1 (en) | 2002-07-15 | 2006-01-05 | John Simard | Immunogenic compositions derived from poxviruses and methods of using same |
| GB0217198D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| GB0217382D0 (en) | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
| USD489448S1 (en) | 2002-07-31 | 2004-05-04 | Advanced Inhalations Revolutions, Inc. | Vaporization apparatus |
| PT1386630E (pt) | 2002-07-31 | 2006-09-29 | Chiesi Farma Spa | Inalador em po |
| US20150283213A1 (en) | 2002-08-01 | 2015-10-08 | Mannkind Corporation | Method for treating hyperglycemia with glp-1 |
| DE10235168A1 (de) | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
| US20040038865A1 (en) | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
| EP1545457A4 (en) | 2002-08-01 | 2009-07-01 | Mannkind Corp | CELL TRANSPORT COMPOSITIONS AND USES |
| US20080260838A1 (en) | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
| GB0315791D0 (en) | 2003-07-07 | 2003-08-13 | 3M Innovative Properties Co | Two component molded valve stems |
| US20040121964A1 (en) | 2002-09-19 | 2004-06-24 | Madar David J. | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| US7322352B2 (en) | 2002-09-21 | 2008-01-29 | Aventis Pharma Limited | Inhaler |
| USD509296S1 (en) | 2002-09-21 | 2005-09-06 | Aventis Pharma Limited | Inhaler |
| JP2004121061A (ja) | 2002-10-01 | 2004-04-22 | Sanei Gen Ffi Inc | 粉末組成物の製造方法 |
| EP1452198A4 (en) | 2002-10-11 | 2006-11-02 | Otsuka Pharma Co Ltd | INHALATION DEVICE FOR POWDER |
| CN1176649C (zh) | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| ITMO20020297A1 (it) | 2002-10-16 | 2004-04-17 | Roberto Oliva | Inalatore per preparati monodose in capsule. |
| NZ540318A (en) | 2002-10-31 | 2007-09-28 | Umd Inc | Therapeutic compositions for drug delivery to and through covering epithelia |
| GB0225621D0 (en) | 2002-11-02 | 2002-12-11 | Glaxo Group Ltd | Medicament carrier |
| AU2003276447A1 (en) | 2002-11-04 | 2004-06-07 | Cambridge Consultants Limited | Inhalers |
| USD493220S1 (en) | 2002-11-06 | 2004-07-20 | Merck Patent Gmbh | Inhaler |
| US20080015457A1 (en) | 2002-11-07 | 2008-01-17 | Silva Carlos D | Device for Monitoring Respiratory Movements |
| USD483860S1 (en) | 2002-11-12 | 2003-12-16 | Pari Gmbh Spezialisten Fur Effektive Inhalation | Electronic inhaler and control unit |
| US6904907B2 (en) | 2002-11-19 | 2005-06-14 | Honeywell International Inc. | Indirect flow measurement through a breath-operated inhaler |
| GB0227128D0 (en) | 2002-11-20 | 2002-12-24 | Glaxo Group Ltd | A capsule |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| US20040138099A1 (en) | 2002-11-29 | 2004-07-15 | Draeger Eberhard Kurt | Insulin administration regimens for the treatment of subjects with diabetes |
| KR20050085237A (ko) | 2002-12-02 | 2005-08-29 | 더 거버너스 오브 더 유니버시티 오브 알버타 | 흡입용 분말로 분쇄하기 위한 장치 및 방법 |
| US7284553B2 (en) | 2002-12-12 | 2007-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
| HRP20050638A2 (en) | 2002-12-13 | 2007-03-31 | Otsuka Pharmaceutical Co. | Inhalation device for transpulmonary administration |
| JP2006516262A (ja) | 2002-12-17 | 2006-06-29 | ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド | Y2受容体結合ペプチドの粘膜送達促進のための組成物および方法ならびに肥満症の治療法および予防法 |
| US6941947B2 (en) | 2002-12-18 | 2005-09-13 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
| US7185650B2 (en) | 2002-12-19 | 2007-03-06 | Arie Huber | Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time |
| US6962006B2 (en) | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
| NZ541365A (en) | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| DE10300032B3 (de) | 2003-01-03 | 2004-05-27 | E. Braun Gmbh | Pulverinhalator |
| GB0309154D0 (en) | 2003-01-14 | 2003-05-28 | Aventis Pharma Inc | Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
| US20040187869A1 (en) | 2003-01-17 | 2004-09-30 | Schering Corporation | Training device for medicament inhalers |
| WO2004071490A1 (en) | 2003-02-12 | 2004-08-26 | R & P Korea Co., Ltd. | Solvent system of hardly soluble drug with improved elution rate |
| GB0303870D0 (en) | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
| US20040171518A1 (en) | 2003-02-27 | 2004-09-02 | Medtronic Minimed, Inc. | Compounds for protein stabilization and methods for their use |
| WO2004078198A1 (en) | 2003-03-04 | 2004-09-16 | The Technology Development Company Ltd. | Long acting injectable insulin composition and methods of making and using thereof |
| US7331340B2 (en) | 2003-03-04 | 2008-02-19 | Ivax Corporation | Medicament dispensing device with a display indicative of the state of an internal medicament reservoir |
| EP1605895A4 (en) | 2003-03-06 | 2011-08-24 | Emisphere Tech Inc | ORAL INSULIN THERAPIES AND PROTOCOL |
| CA2458288A1 (en) | 2003-03-11 | 2004-09-11 | Institut De Cardiologie De Montreal / Montreal Heart Institute | Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| USD499802S1 (en) | 2003-04-01 | 2004-12-14 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
| CA2520265C (en) | 2003-04-09 | 2015-02-17 | Bgp Products Operations Gmbh | Aerosolization apparatus with capsule puncture alignment guide |
| US20040204439A1 (en) | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
| EP1468935A1 (de) | 2003-04-16 | 2004-10-20 | Alcan Technology & Management Ltd. | Blisterverpackung |
| AU155845S (en) | 2003-05-15 | 2004-07-13 | Glaxo Group Ltd | A dispensing device for example an inhaler device |
| CN102210852B (zh) | 2003-05-15 | 2016-10-19 | 安皮奥制药股份有限公司 | T-细胞介导的疾病的治疗 |
| AU155632S (en) | 2003-05-16 | 2004-06-01 | Henkel Kgaa | Blister pack |
| US20070006876A1 (en) | 2003-05-16 | 2007-01-11 | University Of Alberta | Add-on spacer design concept for dry-powder inhalers |
| GB0312007D0 (en) | 2003-05-24 | 2003-07-02 | Innovata Biomed Ltd | Container |
| ES2596553T3 (es) | 2003-06-02 | 2017-01-10 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido |
| AU2004249166B2 (en) | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
| EP1641671B1 (en) | 2003-06-27 | 2015-06-24 | Portaclave LLP | Portable fuel cartridge for fuel cells |
| US7001622B1 (en) | 2003-06-30 | 2006-02-21 | Robert Berndt | Composition and method for treatment and prevention of pruritis |
| GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
| AU158576S (en) | 2003-07-05 | 2006-08-22 | Clinical Designs Ltd | Inhaler |
| US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
| US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
| USD569967S1 (en) | 2003-08-06 | 2008-05-27 | Meridica Limited | Inhaler |
| DE10338402A1 (de) | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| US20050043247A1 (en) | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative |
| US20050056535A1 (en) | 2003-09-15 | 2005-03-17 | Makoto Nagashima | Apparatus for low temperature semiconductor fabrication |
| DE10343668A1 (de) | 2003-09-18 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittelblister |
| WO2005037798A2 (en) | 2003-10-16 | 2005-04-28 | Cara Therapeutics, Inc | Amide or thiomide derivatives and their use in the treatment of pain |
| GB2398065A (en) | 2003-10-16 | 2004-08-11 | Bespak Plc | Dispensing apparatus |
| WO2005041022A1 (en) | 2003-10-24 | 2005-05-06 | Judy Singley | Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight |
| USD511208S1 (en) | 2003-10-24 | 2005-11-01 | Valois Sas | Metered dose inhaler |
| US7377277B2 (en) | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
| US7451761B2 (en) | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
| WO2005041848A2 (en) | 2003-10-27 | 2005-05-12 | Oriel Therapeutics, Inc. | Dry powder drug containment system packages with tabs, inhalers and associated methods |
| US20050147581A1 (en) | 2003-11-19 | 2005-07-07 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes having improved stability and therapeutic use of the same |
| SE0303269L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
| GB0329884D0 (en) | 2003-12-23 | 2004-01-28 | Glaxo Group Ltd | Method |
| WO2005067898A2 (en) | 2004-01-07 | 2005-07-28 | Nektar Therapeutics | Improved sustained release compositions for pulmonary administration of insulin |
| US20050153874A1 (en) | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
| US20070027063A1 (en) | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
| EP1711220A1 (en) | 2004-01-16 | 2006-10-18 | Biodel, Inc. | Sublingual drug delivery device |
| DE102004006450B4 (de) | 2004-02-05 | 2012-09-27 | Ing. Erich Pfeiffer Gmbh | Dosiervorrichtung |
| USD512777S1 (en) | 2004-02-19 | 2005-12-13 | Chrysalis Technologies Incorporated | Inhaler |
| DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
| PL1718353T3 (pl) | 2004-02-24 | 2020-06-01 | Microdose Therapeutx, Inc. | Urządzenie do dostarczania leku na bazie strugi syntetycznej |
| EP1718354B1 (en) | 2004-02-24 | 2020-04-29 | MicroDose Therapeutx, Inc. | Inhaler with a directional flow sensor |
| EP2106790B1 (en) | 2004-03-12 | 2012-10-24 | Biodel, Inc. | Rapid acting drug delivery compositions |
| ITMO20040060A1 (it) | 2004-03-18 | 2004-06-18 | Roberto Oliva | Inalatore per preparati in polvere |
| USD515696S1 (en) | 2004-03-19 | 2006-02-21 | Innovata Biomed Limited | Inhaler |
| WO2005092301A1 (en) | 2004-03-26 | 2005-10-06 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
| US8071552B2 (en) | 2004-04-05 | 2011-12-06 | Universite Bordeaux 2 | Peptides and peptidomimetics binding to CD23 |
| USD533268S1 (en) | 2004-04-18 | 2006-12-05 | Bahram Olfati | Inhaler |
| WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
| WO2005102428A1 (en) | 2004-04-23 | 2005-11-03 | The Governors Of The University Of Alberta | Enhanced drug delivery for inhaled aerosols |
| HUE026152T2 (en) | 2004-04-23 | 2016-05-30 | Philip Morris Products Sa | Aerosol Generator and Method for Aerosol Production |
| GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
| USD527817S1 (en) | 2004-05-13 | 2006-09-05 | Novartis Ag | Inhaler |
| US20050265927A1 (en) | 2004-05-17 | 2005-12-01 | Yale University | Intranasal delivery of nucleic acid molecules |
| WO2005113043A1 (en) | 2004-05-19 | 2005-12-01 | Cipla Limited | Medicament inhaler device |
| USD548833S1 (en) | 2004-05-28 | 2007-08-14 | Quadrant Technologies Limited | Dry powder inhaler |
| USD529604S1 (en) | 2004-05-28 | 2006-10-03 | Quadrant Technologies Limited | Dry powder inhaler |
| JP2008501473A (ja) | 2004-06-07 | 2008-01-24 | メデリオ アーゲー | 吸入可能な薬剤のドーズ品質の保証 |
| SE528190C2 (sv) | 2004-06-07 | 2006-09-19 | Mederio Ag | Inhalator |
| WO2006001499A2 (en) | 2004-06-25 | 2006-01-05 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| US20060000469A1 (en) | 2004-07-02 | 2006-01-05 | Tseng Daniel C | Nebulizing apparatus for medical use with improved nozzle positioning structure |
| CA2574642A1 (en) | 2004-07-23 | 2006-01-26 | Intercure Ltd. | Apparatus and method for breathing pattern determination using a non-contact microphone |
| AU2005266789B2 (en) | 2004-07-26 | 2010-11-25 | 1355540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
| EA200700391A1 (ru) | 2004-08-03 | 2007-10-26 | Байорексис Текнолоджи, Инк. | Комбинированное лечение с применением слитых белков трансферрина, содержащих glp-1 |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| BRPI0514410A (pt) | 2004-08-23 | 2008-06-10 | Mannkind Corp | fornecimento pulmonar de inibidores de fosfodiesterase do tipo 5 |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| GB0419849D0 (en) | 2004-09-07 | 2004-10-13 | Pfizer Ltd | Pharmaceutical combination |
| WO2006031775A2 (en) | 2004-09-13 | 2006-03-23 | Oriel Therapeutics, Inc. | Dry powder inhalers that inhibit agglomeration, related devices and methods |
| US8210171B2 (en) | 2004-09-13 | 2012-07-03 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
| USD537936S1 (en) | 2004-09-15 | 2007-03-06 | Glaxo Group Limited | Cap with an extension, particularly for a dust cap of a metered dose inhaler |
| USD537522S1 (en) | 2004-09-15 | 2007-02-27 | Glaxo Group Limited | Telescopic strap, particularly for a dust cap of a metered dose inhaler |
| USD518170S1 (en) | 2004-09-28 | 2006-03-28 | Vectura, Ltd. | Inhaler |
| AU2005291427A1 (en) | 2004-10-06 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
| US7469696B2 (en) | 2004-10-13 | 2008-12-30 | Hewlett-Packard Development Company, L.P. | Thermal drop generator |
| USD515924S1 (en) | 2004-11-01 | 2006-02-28 | Warner-Lambert Company Llc | Blister card |
| DE102005033398A1 (de) | 2004-11-10 | 2006-05-11 | Alfred Von Schuckmann | Inhalier-Gerät |
| SE0402976L (sv) | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
| CA2589118A1 (en) | 2004-12-03 | 2006-06-08 | Mederio Ag | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
| GB0427028D0 (en) | 2004-12-09 | 2005-01-12 | Cambridge Consultants | Dry powder inhalers |
| KR20070090036A (ko) | 2004-12-22 | 2007-09-04 | 센토코 인코포레이티드 | Glp-1 작용제, 조성물, 방법 및 용도 |
| WO2006086107A2 (en) | 2005-01-10 | 2006-08-17 | Mannkind Corporation | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| US20060165756A1 (en) | 2005-01-27 | 2006-07-27 | Catani Steven J | Method for weight management |
| USD538423S1 (en) | 2005-02-04 | 2007-03-13 | Berube-White | Panda bear inhaler |
| GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| US20060219242A1 (en) | 2005-03-30 | 2006-10-05 | Boehringer Ingelheim International | Method for the Administration of an Anticholinergic by Inhalation |
| JP4656397B2 (ja) | 2005-03-31 | 2011-03-23 | 株式会社吉野工業所 | 粉体用容器 |
| CN100431634C (zh) | 2005-04-04 | 2008-11-12 | 陈庆堂 | 干粉气溶胶化吸入器 |
| US7762953B2 (en) | 2005-04-20 | 2010-07-27 | Adidas Ag | Systems and methods for non-invasive physiological monitoring of non-human animals |
| US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
| MX2007013356A (es) | 2005-04-27 | 2008-03-26 | Baxter Int | Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas. |
| US7219664B2 (en) | 2005-04-28 | 2007-05-22 | Kos Life Sciences, Inc. | Breath actuated inhaler |
| MX2007013272A (es) | 2005-05-02 | 2008-01-22 | Astrazeneca Ab | Arreglo y metodo para abrir una cavidad, empaque medico y dispositivo de suministro. |
| USD544093S1 (en) | 2005-06-02 | 2007-06-05 | Bang & Olufsen A/S | Inhaler |
| PT2656860T (pt) | 2005-06-17 | 2021-07-28 | Wisconsin Alumni Res Found | Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro |
| EP1901793A1 (en) | 2005-07-13 | 2008-03-26 | Cipla Ltd. | Inhaler device |
| US8763605B2 (en) | 2005-07-20 | 2014-07-01 | Manta Devices, Llc | Inhalation device |
| USD550835S1 (en) | 2005-07-22 | 2007-09-11 | Omron Healthcare Co., Ltd. | Atomizer for inhaler |
| EP1915171B1 (en) | 2005-08-01 | 2013-11-20 | MannKind Corporation | Method of preserving the function of insulin-producing cells |
| JP5694643B2 (ja) | 2005-08-05 | 2015-04-01 | スリーエム イノベイティブ プロパティズ カンパニー | 改善された流動性を示す組成物 |
| CA2618520C (en) | 2005-08-25 | 2015-01-27 | Oriel Therapeutics, Inc. | Drug containment systems with sticks, related kits, dry powder inhalers and methods |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| WO2008048234A2 (en) | 2005-08-26 | 2008-04-24 | North Carolina State University | Inhaler system for targeted maximum drug-aerosol delivery |
| JP2007061281A (ja) | 2005-08-30 | 2007-03-15 | Hitachi Ltd | 吸入量測定システム |
| WO2007030706A1 (en) | 2005-09-08 | 2007-03-15 | New England Medical Center Hospitals, Inc. | Fragments of the glucagon-like peptide-i and uses thereof |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| USD540671S1 (en) | 2005-09-21 | 2007-04-17 | The Procter & Gamble Company | Cap for product dispenser |
| US20070086952A1 (en) | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
| US20070074989A1 (en) | 2005-09-30 | 2007-04-05 | Musculoskeletal Transplant Foundation | Container for lyophilization and storage of tissue |
| GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
| ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| USD566549S1 (en) | 2005-10-26 | 2008-04-15 | Reckitt Benckiser (Uk) Limited | Cap |
| US8039432B2 (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect |
| AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
| AR058290A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Dispensador de medicamento |
| WO2007075534A2 (en) | 2005-12-16 | 2007-07-05 | Nektar Therapeutics Al, Corporation | Polymer conjugates of glp-1 |
| WO2007114881A1 (en) | 2006-01-24 | 2007-10-11 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| USD557799S1 (en) | 2006-01-25 | 2007-12-18 | Valois S.A.S. | Inhaler |
| US7390949B2 (en) | 2006-02-01 | 2008-06-24 | Wanne, Inc. | Saxophone and clarinet mouthpiece cap |
| GB0602897D0 (en) | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
| WO2007094833A1 (en) | 2006-02-14 | 2007-08-23 | Battelle Memorial Institute | Accurate metering system |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| EP2471810A1 (en) | 2006-02-22 | 2012-07-04 | Merck Sharp & Dohme Corporation | Oxyntomodulin derivatives |
| DE102006010089A1 (de) | 2006-02-24 | 2007-10-18 | Aha-Kunststofftechnik Gmbh | Trockenpulver-Inhalator |
| USD541151S1 (en) | 2006-03-20 | 2007-04-24 | The Procter & Gamble Company | Cap for product dispenser |
| US8037880B2 (en) | 2006-04-07 | 2011-10-18 | The University Of Western Ontario | Dry powder inhaler |
| WO2007121256A2 (en) | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
| EP1844809A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator |
| EP1844806A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH | Medikamenten-Ausgabevorrichtung, Medikamentenmagazin dafür, und Verfahren zur Entnahme eines Medikaments aus einer Medikamentenkammer |
| RU2409349C2 (ru) | 2006-04-14 | 2011-01-20 | Маннкайнд Корпорейшн | Фармацевтические композиции, содержащие глюкагонподобный пептид(glp-1) |
| GR1005620B (el) | 2006-05-09 | 2007-09-03 | Βελτιωση συσκευης εισπνοων ξηρης σκονης | |
| JPWO2007129515A1 (ja) | 2006-05-10 | 2009-09-17 | 株式会社スカイネット | 小動物用麻酔システム |
| DE102006021978A1 (de) | 2006-05-10 | 2007-11-15 | Robert Bosch Gmbh | Vorrichtung und Verfahen zum Verstärken eines Blisters |
| PT103481B (pt) | 2006-05-16 | 2008-08-01 | Hovione Farmaciencia S A | Inalador de uso simples e método de inalação |
| GB0611659D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
| GB0611656D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
| CA2655477C (en) | 2006-06-16 | 2015-05-05 | Cipla Limited | Vibration assisted release of encapsulated inhalable powder |
| US8201555B2 (en) | 2006-06-27 | 2012-06-19 | Brintech International Limited | Inhaler |
| RU2436599C2 (ru) | 2006-06-27 | 2011-12-20 | Оцука Фармасьютикал Ко., Лтд. | Порошковый ингалятор |
| GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| JP2009543658A (ja) | 2006-07-14 | 2009-12-10 | アストラゼネカ・アクチエボラーグ | 乾燥粉末状の薬を投与するための吸入装置及び配送装置 |
| MX2009001351A (es) | 2006-08-04 | 2009-05-11 | Manus Pharmaceuticals Canada L | Compuestos bioactivos multifuncionales. |
| GB0616299D0 (en) | 2006-08-16 | 2006-09-27 | Cambridge Consultants | Drug Capsules for dry power inhalers |
| US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| WO2008039863A2 (en) | 2006-09-27 | 2008-04-03 | Braincells, Inc. | Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
| JP5244810B2 (ja) | 2006-11-10 | 2013-07-24 | カラ セラピューティクス インコーポレイテッド | 合成ペプチドアミド |
| US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| EP2086691A2 (en) | 2006-11-10 | 2009-08-12 | Proveris Scientific Corporation | Automated nasal spray pump testing |
| US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| USD548619S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
| USD548618S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
| USD549111S1 (en) | 2006-12-06 | 2007-08-21 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
| CN101600469B (zh) | 2006-12-22 | 2013-10-23 | 奥米罗有限公司 | 药粉吸入装置 |
| WO2008092864A1 (en) | 2007-01-29 | 2008-08-07 | Novo Nordisk A/S | Method and devices for aerosolizing a drug formulation |
| US8172817B2 (en) | 2007-01-31 | 2012-05-08 | Allegiance Corporation | Liquid collection system and related methods |
| NZ578948A (en) | 2007-02-15 | 2012-03-30 | Univ Indiana Res & Tech Corp | Glucagon/glp-1 receptor co-agonists |
| US8196576B2 (en) | 2007-02-28 | 2012-06-12 | Microdose Therapeutx, Inc. | Inhaler |
| WO2009005546A1 (en) | 2007-03-05 | 2009-01-08 | Board of Governors for Higher Education, State of Rhode Island and the Providence Plantations | High efficiency mouthpiece/adaptor for inhalers |
| JP2008212436A (ja) | 2007-03-06 | 2008-09-18 | Canon Inc | 吸入装置 |
| US8146745B2 (en) | 2007-03-09 | 2012-04-03 | Cardpak, Inc. | Environmentally separable packaging device with attaching base |
| GB0704928D0 (en) | 2007-03-14 | 2007-04-25 | Cambridge Consultants | Dry powder inhalers |
| JP2011505925A (ja) | 2007-04-11 | 2011-03-03 | スター ライフ サイエンシーズ コーポレイション | 移動性の動物用の非侵襲性フォトプレチスモグラフィセンサプラットフォーム |
| JP4417400B2 (ja) | 2007-04-16 | 2010-02-17 | アンリツ株式会社 | はんだ検査ライン集中管理システム、及びそれに用いられる管理装置 |
| EP2157967B1 (en) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspension formulations of insulinotropic peptides and uses thereof |
| HUE034380T2 (en) | 2007-04-30 | 2018-02-28 | Sun Pharma Advanced Res Co Ltd | Inhalation device |
| USD577815S1 (en) | 2007-04-30 | 2008-09-30 | Sun Pharma Advanced Research Company Limited | Inhaler |
| USD583463S1 (en) | 2007-04-30 | 2008-12-23 | Sun Pharma Advanced Research Company Limited | Inhaler |
| CN105776119B (zh) | 2007-05-16 | 2019-04-23 | 神秘制药公司 | 组成物单位剂量分配容器 |
| EP1992378A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
| USD579547S1 (en) | 2007-06-07 | 2008-10-28 | Novartis Ag | Inhaler |
| EA201000046A1 (ru) | 2007-06-21 | 2011-02-28 | Кара Терапеутикс, Инк. | Замещенные имидазогетероциклы |
| EP2170444B1 (en) | 2007-07-06 | 2016-09-07 | Manta Devices, LLC | Inhalation devices for storing and delivering medicament |
| US20090084379A1 (en) | 2007-10-02 | 2009-04-02 | Baxter International Inc. | Dry powder inhaler |
| EP2048112A1 (en) | 2007-10-09 | 2009-04-15 | Kemira Kemi AB | Use of a nozzle for manufacturing sodium percarbonate |
| KR101736502B1 (ko) | 2007-10-24 | 2017-05-16 | 맨카인드 코포레이션 | Glp-1에 의한 유해 효과의 예방 방법 |
| KR20100090692A (ko) | 2007-10-24 | 2010-08-16 | 맨카인드 코포레이션 | 활성제의 전달 |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| RU2517140C2 (ru) | 2007-10-25 | 2014-05-27 | Новартис Аг | Способ обработки упаковки с однократной дозой лекартвенного препарата |
| GB0721394D0 (en) | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
| WO2009061891A2 (en) | 2007-11-06 | 2009-05-14 | 3M Innovative Properties Company | Medicinal inhalation devices and components thereof |
| EP2060268A1 (en) | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
| EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
| USD594753S1 (en) | 2007-12-14 | 2009-06-23 | The Procter & Gamble Company | Blister card |
| NZ586106A (en) | 2007-12-20 | 2012-09-28 | Astrazeneca Ab | Device, typically for medicament powder, for deaggregating powder by passing air stream along flat region with recess of brick shape where eddy is generated |
| US7584846B2 (en) | 2007-12-21 | 2009-09-08 | S.C. Johnson & Son, Inc. | Shaped packaging for a refill |
| US20110077272A1 (en) | 2008-02-01 | 2011-03-31 | Vectura Limited | Pulmonary formulations of triptans |
| GB0802028D0 (en) | 2008-02-05 | 2008-03-12 | Dunne Stephen T | Powder inhaler flow regulator |
| USD614045S1 (en) | 2008-02-22 | 2010-04-20 | Ima Safe S.R.L. | Blister packaging |
| CA2719205C (en) | 2008-03-27 | 2017-04-25 | Mannkind Corporation | A dry powder inhalation system |
| EP2282763B1 (en) | 2008-04-07 | 2013-12-11 | National Institute Of Immunology | Process for preparing supramolecular calcitonin assemblies (SCA) |
| US8834930B2 (en) | 2008-05-15 | 2014-09-16 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| USD598785S1 (en) | 2008-05-22 | 2009-08-25 | Wm. Wrigley Jr. Company | Blister card |
| USD597418S1 (en) | 2008-05-22 | 2009-08-04 | Wm. Wrigley Jr. Company | Blister card |
| USD613849S1 (en) | 2008-06-13 | 2010-04-13 | Mannkind Corporation | Cartridge for a dry powder inhaler |
| USD614760S1 (en) | 2008-06-13 | 2010-04-27 | Mannkind Corporation | Dry powder inhaler |
| USD597657S1 (en) | 2008-06-13 | 2009-08-04 | Mannkind Corporation | Dry powder inhaler |
| USD604832S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Cartridge for a dry powder inhaler |
| USD605753S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Cartridge for a dry powder inhaler |
| USD604833S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Dry powder inhaler |
| USD605752S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Dry powder inhaler |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| USD635241S1 (en) | 2008-06-13 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| USD629887S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
| USD629506S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
| USD629888S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
| USD629505S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
| USD635242S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
| USD629886S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
| USD635243S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| CA2748490C (en) | 2008-12-29 | 2016-10-04 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| SI2379100T1 (sl) | 2009-01-08 | 2015-02-27 | Mannkind Corporation | Zdravljenje hiperglikemije z GLP-1 |
| US8550074B2 (en) | 2009-01-15 | 2013-10-08 | Manta Devices, Llc | Delivery device and related methods |
| MX2011009251A (es) | 2009-03-04 | 2011-11-18 | Mannkind Corp | Sistema mejorado de suministro de farmaco en polvo seco. |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| CA2992927A1 (en) | 2009-03-18 | 2010-09-23 | Mannkind Corporation | Inhaler adaptor for a laser diffraction apparatus and method for measuring particle size distribution |
| GB0907425D0 (en) | 2009-04-29 | 2009-06-10 | Glaxo Group Ltd | Compounds |
| USD626836S1 (en) | 2009-04-30 | 2010-11-09 | Bryce Lien | Bottle cap |
| USD628090S1 (en) | 2009-05-07 | 2010-11-30 | Mccormick & Company, Incorporated | Seasoning package |
| USD620375S1 (en) | 2009-05-11 | 2010-07-27 | Mcneil-Ppc, Inc. | Blister |
| CA2762819C (en) | 2009-05-21 | 2016-12-20 | Microdose Therapeutx, Inc. | Rotary cassette system for dry powder inhaler |
| PT2435025T (pt) | 2009-05-29 | 2016-11-11 | Pearl Therapeutics Inc | Administração, por via respiratória, de agentes activos |
| SG10201403147SA (en) | 2009-06-12 | 2014-10-30 | Mannkind Corp | Diketopiperazine microparticles with defined isomer contents |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| US9180263B2 (en) | 2009-07-01 | 2015-11-10 | Microdose Therapeutx, Inc. | Laboratory animal pulmonary dosing device |
| EP2482840A4 (en) | 2009-08-07 | 2013-06-26 | Mannkind Corp | VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME |
| CA2770714A1 (en) | 2009-08-27 | 2011-03-17 | Stc.Unm | Methods and systems for dosing and coating inhalation powders onto carrier particles |
| IT1395945B1 (it) | 2009-09-30 | 2012-11-02 | Oliva | Inalatore perfezionato per preparati in polvere |
| USD647195S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
| USD647196S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| USD650295S1 (en) | 2009-11-13 | 2011-12-13 | Avidiamed Gmbh | Blister pack for pharmaceuticals |
| AU2010336338B2 (en) | 2009-12-23 | 2015-02-19 | Map Pharmaceuticals, Inc. | Enhanced eductor design |
| EP2519249A4 (en) | 2009-12-31 | 2013-06-26 | Stealth Peptides Int Inc | METHOD FOR CARRYING OUT A CORONARY ARTERY BYPASS PROCEDURE |
| AU332056S (en) | 2010-01-08 | 2010-08-04 | Teva Pharma Ireland | Inhaler |
| USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
| GB201006901D0 (en) | 2010-04-26 | 2010-06-09 | Sagentia Ltd | Device for monitoring status and use of an inhalation or nasal drug delivery device |
| PT105065B (pt) | 2010-04-26 | 2012-07-31 | Hovione Farmaciencia S A | Um inalador simples de cápsulas |
| USD645954S1 (en) | 2010-05-21 | 2011-09-27 | Consort Medical Plc | Mechanical dosage counter apparatus |
| USD636867S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
| USD636868S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
| USD636869S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| CN101851213A (zh) | 2010-06-21 | 2010-10-06 | 于清 | 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法 |
| USD643308S1 (en) | 2010-09-28 | 2011-08-16 | Mannkind Corporation | Blister packaging |
| MX376862B (es) | 2010-11-09 | 2025-03-07 | Mannkind Corp | Composicion que comprende un agonista de receptor de serotonina y una dicetopiperazina para el tratamiento de migrañas. |
| CA140810S (en) | 2010-12-01 | 2012-05-23 | Teva Pharma | Inhaler cap |
| USD642483S1 (en) | 2010-12-03 | 2011-08-02 | Mccormick & Company, Incorporated | Seasoning package |
| EP2673265B1 (en) * | 2011-02-10 | 2016-10-19 | MannKind Corporation | Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| RS58456B1 (sr) | 2011-08-01 | 2019-04-30 | Univ Monash | Postupak i formulacije za inhalaciju |
| USD674893S1 (en) | 2011-10-20 | 2013-01-22 | Mannkind Corporation | Inhaler device |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| CN102436238B (zh) | 2011-11-03 | 2014-04-16 | 广东轻工职业技术学院 | 基于生产线数据采集及信息管理系统的数据采集方法 |
| BR112014026809A2 (pt) | 2012-04-27 | 2017-06-27 | Mannkind Corp | métodos para a síntese de etilfumaratos ativados e seu uso como intermediários |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| EP2890391A4 (en) | 2012-08-29 | 2016-03-09 | Mannkind Corp | METHOD AND COMPOSITION FOR TREATING HYPERGLYCEMIA |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| USD711740S1 (en) | 2013-01-22 | 2014-08-26 | H204K9, Inc. | Bottle cap |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| GB201319265D0 (en) | 2013-10-31 | 2013-12-18 | Norton Waterford Ltd | Medicament inhaler |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| USD771237S1 (en) | 2014-10-02 | 2016-11-08 | Mannkind Corporation | Mouthpiece cover |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
-
2005
- 2005-08-19 AT AT05792739T patent/ATE486064T1/de not_active IP Right Cessation
- 2005-08-19 PL PL05792739T patent/PL1786784T3/pl unknown
- 2005-08-19 DE DE602005024413T patent/DE602005024413D1/de not_active Expired - Lifetime
- 2005-08-19 AU AU2005277208A patent/AU2005277208B2/en not_active Ceased
- 2005-08-19 KR KR1020077005825A patent/KR101273120B1/ko not_active Expired - Fee Related
- 2005-08-19 EP EP05792739A patent/EP1786784B1/en not_active Expired - Lifetime
- 2005-08-19 MX MX2007001903A patent/MX2007001903A/es active IP Right Grant
- 2005-08-19 WO PCT/US2005/029777 patent/WO2006023849A2/en not_active Ceased
- 2005-08-19 CA CA2575692A patent/CA2575692C/en not_active Expired - Lifetime
- 2005-08-19 JP JP2007528088A patent/JP5078014B2/ja not_active Expired - Fee Related
- 2005-08-19 BR BRPI0514263A patent/BRPI0514263B8/pt not_active IP Right Cessation
- 2005-08-19 ES ES05792739T patent/ES2385934T3/es not_active Expired - Lifetime
- 2005-08-19 DK DK05792739.4T patent/DK1786784T3/da active
- 2005-08-19 CN CN2005800279682A patent/CN101010305B/zh not_active Expired - Fee Related
- 2005-08-19 US US11/208,087 patent/US7709639B2/en active Active
-
2007
- 2007-01-31 IL IL181091A patent/IL181091A/en active IP Right Grant
-
2009
- 2009-12-08 US US12/633,673 patent/US8202992B2/en not_active Expired - Lifetime
-
2011
- 2011-12-21 IL IL217128A patent/IL217128A0/en active IP Right Grant
-
2012
- 2012-03-16 US US13/422,989 patent/US8748609B2/en not_active Expired - Fee Related
-
2014
- 2014-04-30 US US14/266,632 patent/US9346766B2/en not_active Expired - Lifetime
-
2016
- 2016-04-12 US US15/097,124 patent/US9796688B2/en not_active Expired - Fee Related
-
2017
- 2017-09-07 US US15/698,431 patent/US10112910B2/en not_active Expired - Lifetime
-
2018
- 2018-10-04 US US16/151,797 patent/US10604491B2/en not_active Expired - Lifetime
-
2020
- 2020-02-24 US US16/798,690 patent/US11292774B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11292774B2 (en) | Catalysis of diketopiperazine synthesis | |
| EP2673265B1 (en) | Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine | |
| CN103619852B (zh) | 利福昔明的多晶型物及其制备方法 | |
| CN111315722A (zh) | 制备月桂酰阿立哌唑的方法 | |
| RS51912B (sr) | DERIVATI 1,2,3,4-TETRAHIDROPIROLO(1,2-a)PIRAZIN-6-KARBOKSAMIDA I 2,3,4,5-TETRAHIDROPIROLO(1,2-a)(1,4)-DIAZEPIN-7-KARBOKSAMIDA NJIHOVO DOBIJANJE I TERAPEUTSKA PRIMENA | |
| PT1278721E (pt) | Processo para a preparação de compostos de pirazina. | |
| CA1198110A (en) | Alkanolamine derivatives | |
| Zaragoza | Solid phase synthesis of cyanoacetamidines: Fast access to potential bioisosteres of acceptor-substituted guanidines | |
| HK1105294B (en) | Catalysis of diketopiperazine synthesis | |
| CN114920663B (zh) | 一种联苯类奥司他韦衍生物及其制备方法与应用 | |
| PT593286E (pt) | Intermediarios para a sintese de compostos anti-folato e processos de os obter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/08/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 20A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2846 DE 22-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |


